| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.806 | 0.004 | 0.806 | Aldehyde oxidase inhibitor | 0.633 0.015 CID_15361578 0.727 0.006 CID_125 | ||
| 0.654 | 0.004 | 0.654 | Peroxidase inhibitor | 0.394 0.021 CID_15361578 0.602 0.004 CID_125 | ||
| 0.665 | 0.028 | 0.757 | Caspase 9 stimulant | 0.669 0.028 CID_15361578 0.757 0.017 CID_125 0.623 0.033 CID_66849195 | CID_125 | |
| 0.641 | 0.005 | 0.641 | GABA C receptor rho-3 antagonist | 0.554 0.014 CID_15361578 0.557 0.013 CID_125 | ||
| 0.638 | 0.003 | 0.638 | Alcohol oxidase inhibitor | 0.173 0.008 CID_15361578 0.596 0.003 CID_125 0.069 0.029 CID_66849195 | ||
| 0.645 | 0.011 | 0.646 | 5 Hydroxytryptamine release stimulant | 0.534 0.022 CID_15361578 0.646 0.01 CID_125 0.469 0.033 CID_66849195 | CID_125 | |
| 0.624 | 0.008 | 0.694 | 5 Hydroxytryptamine release inhibitor | 0.475 0.041 CID_15361578 0.513 0.029 CID_125 0.694 0.004 CID_66849195 | CID_66849195 | |
| 0.567 | 0.01 | 0.596 | Calcium channel L-type activator | 0.44 0.056 CID_15361578 0.596 0.006 CID_125 0.275 0.18 CID_66849195 | CID_125 | |
| 0.532 | 0.004 | 0.532 | Tyrosine 3 hydroxylase inhibitor | 0.387 0.01 CID_15361578 0.473 0.004 CID_125 | ||
| 0.55 | 0.025 | 0.732 | Cholesterol antagonist | 0.51 0.031 CID_15361578 0.661 0.011 CID_125 0.732 0.006 CID_66849195 | CID_66849195 | |
| 0.534 | 0.019 | 0.66 | Histamine release inhibitor | 0.405 0.073 CID_15361578 0.497 0.03 CID_125 0.66 0.006 CID_66849195 | CID_66849195 | |
| 0.513 | 0.012 | 0.513 | Superoxide dismutase inhibitor | 0.299 0.051 CID_15361578 0.438 0.021 CID_125 | ||
| 0.502 | 0.005 | 0.725 | Alpha-N-acetylglucosaminidase inhibitor | 0.321 0.014 CID_15361578 0.662 0.003 CID_125 0.725 0.003 CID_66849195 | CID_66849195 | |
| 0.5 | 0.003 | 0.624 | Porphobilinogen synthase inhibitor | 0.214 0.01 CID_15361578 0.624 0.003 CID_125 | CID_125 | |
| 0.513 | 0.028 | 0.513 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.447 0.063 CID_15361578 0.382 0.118 CID_125 0.268 0.259 CID_66849195 | ||
| 0.479 | 0.005 | 0.479 | 5 Hydroxytryptamine uptake stimulant | 0.458 0.006 CID_15361578 0.466 0.005 CID_125 0.214 0.126 CID_66849195 | ||
| 0.488 | 0.017 | 0.677 | Free radical scavenger | 0.466 0.02 CID_125 0.677 0.005 CID_66849195 | CID_66849195 | |
| 0.478 | 0.023 | 0.73 | Antioxidant | 0.223 0.099 CID_15361578 0.514 0.018 CID_125 0.73 0.005 CID_66849195 | CID_66849195 | |
| 0.448 | 0.011 | 0.448 | Calcium channel activator | 0.421 0.018 CID_15361578 0.428 0.016 CID_125 0.252 0.145 CID_66849195 | ||
| 0.439 | 0.004 | 0.439 | Estrogen receptor beta antagonist | 0.101 0.063 CID_15361578 0.304 0.005 CID_125 | ||
| 0.437 | 0.004 | 0.437 | Estrogen antagonist | 0.115 0.065 CID_15361578 0.31 0.006 CID_125 0.102 0.093 CID_66849195 | ||
| 0.433 | 0.003 | 0.433 | Creatine kinase inhibitor | 0.183 0.014 CID_15361578 0.331 0.004 CID_125 0.113 0.047 CID_66849195 | ||
| 0.432 | 0.005 | 0.445 | Neurotrophic factor enhancer | 0.313 0.015 CID_15361578 0.445 0.005 CID_125 0.445 0.005 CID_66849195 | CID_66849195 | |
| 0.454 | 0.028 | 0.454 | 12-Lipoxygenase inhibitor | 0.18 0.174 CID_15361578 0.369 0.049 CID_125 | ||
| 0.43 | 0.008 | 0.748 | Amylase inhibitor | 0.184 0.05 CID_15361578 0.524 0.005 CID_125 0.748 0.003 CID_66849195 | CID_66849195 | |
| 0.447 | 0.028 | 0.447 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.24 0.081 CID_15361578 0.174 0.118 CID_125 | ||
| 0.417 | 0.004 | 0.417 | Cystathionine beta-synthase inhibitor | 0.27 0.013 CID_15361578 0.325 0.008 CID_125 0.35 0.006 CID_66849195 | ||
| 0.426 | 0.013 | 0.426 | Anesthetic general | 0.299 0.033 CID_15361578 0.378 0.019 CID_125 0.405 0.016 CID_66849195 | ||
| 0.458 | 0.051 | 0.458 | 15-Lipoxygenase inhibitor | 0.243 0.17 CID_15361578 0.333 0.109 CID_125 | ||
| 0.42 | 0.017 | 0.42 | Pyruvate kinase inhibitor | 0.151 0.115 CID_15361578 0.223 0.07 CID_125 | ||
| 0.446 | 0.054 | 0.742 | Transcription factor NF kappa B inhibitor | 0.42 0.059 CID_15361578 0.471 0.049 CID_125 0.742 0.017 CID_66849195 | CID_66849195 | |
| 0.405 | 0.018 | 0.405 | RNA-directed DNA polymerase inhibitor | 0.393 0.019 CID_15361578 0.391 0.019 CID_125 0.336 0.026 CID_66849195 | ||
| 0.469 | 0.09 | 0.72 | Alpha-glucosidase inhibitor | 0.409 0.111 CID_125 0.72 0.03 CID_66849195 | CID_66849195 | |
| 0.426 | 0.047 | 0.487 | Vasodilator, peripheral | 0.329 0.083 CID_15361578 0.487 0.03 CID_125 0.402 0.055 CID_66849195 | CID_125 | |
| 0.419 | 0.042 | 0.419 | Streptokinase A inhibitor | |||
| 0.376 | 0.006 | 0.457 | Aldehyde dehydrogenase inhibitor | 0.153 0.045 CID_15361578 0.457 0.005 CID_125 0.328 0.009 CID_66849195 | CID_125 | |
| 0.38 | 0.013 | 0.569 | Melanin inhibitor | 0.199 0.041 CID_15361578 0.324 0.019 CID_125 0.569 0.005 CID_66849195 | CID_66849195 | |
| 0.377 | 0.025 | 0.377 | Sodium/bile acid cotransporter inhibitor | 0.242 0.137 CID_15361578 0.358 0.035 CID_125 0.28 0.098 CID_66849195 | ||
| 0.355 | 0.005 | 0.355 | Ferrochelatase inhibitor | 0.245 0.014 CID_15361578 0.222 0.018 CID_125 | ||
| 0.36 | 0.011 | 0.377 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.236 0.049 CID_15361578 0.377 0.009 CID_125 0.294 0.025 CID_66849195 | CID_125 | |
| 0.438 | 0.096 | 0.662 | Apoptosis agonist | 0.435 0.098 CID_15361578 0.481 0.08 CID_125 0.662 0.037 CID_66849195 | CID_66849195 | |
| 0.348 | 0.007 | 0.348 | GABA C receptor agonist | 0.335 0.007 CID_15361578 0.34 0.007 CID_125 0.088 0.081 CID_66849195 | ||
| 0.349 | 0.008 | 0.487 | UDP-glucose 4-epimerase inhibitor | 0.218 0.016 CID_15361578 0.415 0.005 CID_125 0.487 0.003 CID_66849195 | CID_66849195 | |
| 0.345 | 0.005 | 0.373 | Nitric-oxide synthase stimulant | 0.279 0.018 CID_15361578 0.373 0.004 CID_125 0.343 0.005 CID_66849195 | CID_125 | |
| 0.376 | 0.044 | 0.384 | Lipoxygenase inhibitor | 0.179 0.165 CID_15361578 0.384 0.041 CID_125 | CID_125 | |
| 0.344 | 0.014 | 0.427 | Lipid peroxidase inhibitor | 0.177 0.052 CID_15361578 0.325 0.016 CID_125 0.427 0.008 CID_66849195 | CID_66849195 | |
| 0.341 | 0.012 | 0.441 | NOS3 expression enhancer | 0.355 0.011 CID_15361578 0.242 0.028 CID_125 0.441 0.006 CID_66849195 | CID_66849195 | |
| 0.333 | 0.006 | 0.444 | Carbonic anhydrase XV inhibitor | 0.113 0.053 CID_15361578 0.444 0.004 CID_125 | CID_125 | |
| 0.358 | 0.031 | 0.358 | Insulysin inhibitor | 0.35 0.034 CID_15361578 0.305 0.055 CID_125 | ||
| 0.331 | 0.005 | 0.331 | Estrogen agonist | 0.299 0.005 CID_125 0.089 0.02 CID_66849195 | ||
| 0.334 | 0.009 | 0.334 | M18 aspartyl aminopeptidase inhibitor | 0.146 0.054 CID_125 | ||
| 0.357 | 0.032 | 0.357 | Transcription factor STAT inhibitor | 0.248 0.088 CID_15361578 0.309 0.051 CID_125 | ||
| 0.327 | 0.004 | 0.559 | Triose-phosphate isomerase inhibitor | 0.265 0.006 CID_15361578 0.409 0.003 CID_125 0.559 0.002 CID_66849195 | CID_66849195 | |
| 0.327 | 0.007 | 0.327 | Succinate dehydrogenase inhibitor | 0.264 0.018 CID_15361578 0.31 0.009 CID_125 0.183 0.065 CID_66849195 | ||
| 0.333 | 0.015 | 0.448 | Phospholipase C inhibitor | 0.219 0.034 CID_15361578 0.448 0.008 CID_125 0.239 0.027 CID_66849195 | CID_125 | |
| 0.362 | 0.045 | 0.362 | Aryl hydrocarbon receptor agonist | 0.146 0.139 CID_15361578 0.217 0.093 CID_125 | ||
| 0.322 | 0.017 | 0.496 | Interferon gamma antagonist | 0.299 0.02 CID_15361578 0.284 0.022 CID_125 0.496 0.006 CID_66849195 | CID_66849195 | |
| 0.36 | 0.056 | 0.441 | Caspase 3 stimulant | 0.229 0.133 CID_15361578 0.441 0.032 CID_125 0.377 0.051 CID_66849195 | CID_125 | |
| 0.348 | 0.045 | 0.384 | Hypoxia-inducible factor 1 alpha inhibitor | 0.287 0.072 CID_15361578 0.351 0.044 CID_125 0.384 0.035 CID_66849195 | CID_66849195 | |
| 0.335 | 0.038 | 0.335 | Transcription factor STAT3 inhibitor | 0.269 0.07 CID_15361578 0.309 0.049 CID_125 0.186 0.154 CID_66849195 | ||
| 0.331 | 0.034 | 0.491 | DNA synthesis inhibitor | 0.369 0.026 CID_15361578 0.385 0.024 CID_125 0.491 0.014 CID_66849195 | CID_66849195 | |
| 0.301 | 0.005 | 0.408 | Carbonic anhydrase III inhibitor | 0.098 0.065 CID_15361578 0.408 0.004 CID_125 0.176 0.021 CID_66849195 | CID_125 | |
| 0.3 | 0.005 | 0.314 | Mannose-6-phosphate isomerase inhibitor | 0.179 0.043 CID_15361578 0.273 0.008 CID_125 0.314 0.005 CID_66849195 | CID_66849195 | |
| 0.316 | 0.021 | 0.316 | 5 Hydroxytryptamine 1E antagonist | 0.286 0.039 CID_15361578 0.208 0.122 CID_125 | ||
| 0.349 | 0.056 | 0.543 | Vasodilator, coronary | 0.35 0.055 CID_15361578 0.394 0.037 CID_125 0.543 0.011 CID_66849195 | CID_66849195 | |
| 0.332 | 0.039 | 0.332 | Amyloid beta aggregation inhibitor | 0.277 0.05 CID_125 0.157 0.103 CID_66849195 | ||
| 0.293 | 0.007 | 0.5 | Histidine decarboxylase inhibitor | 0.091 0.036 CID_15361578 0.5 0.003 CID_125 | CID_125 | |
| 0.29 | 0.004 | 0.29 | CF transmembrane conductance regulator agonist | 0.227 0.011 CID_15361578 0.289 0.004 CID_125 0.216 0.014 CID_66849195 | ||
| 0.291 | 0.007 | 0.395 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.207 0.015 CID_15361578 0.358 0.004 CID_125 0.395 0.004 CID_66849195 | CID_66849195 | |
| 0.286 | 0.004 | 0.286 | Phenylalanine 4-hydroxylase inhibitor | 0.085 0.034 CID_15361578 0.274 0.004 CID_125 | ||
| 0.298 | 0.017 | 0.478 | Protein kinase stimulant | 0.244 0.028 CID_15361578 0.389 0.009 CID_125 0.478 0.005 CID_66849195 | CID_66849195 | |
| 0.308 | 0.028 | 0.316 | Gastrin inhibitor | 0.316 0.023 CID_15361578 0.266 0.061 CID_125 0.276 0.052 CID_66849195 | CID_15361578 | |
| 0.325 | 0.045 | 0.752 | Hypoglycemic | 0.487 0.016 CID_125 0.752 0.004 CID_66849195 | CID_66849195 | |
| 0.358 | 0.08 | 0.358 | Prostaglandin dehydrogenase inhibitor | 0.228 0.139 CID_125 | ||
| 0.294 | 0.018 | 0.583 | Monophenol monooxygenase inhibitor | 0.138 0.052 CID_15361578 0.363 0.013 CID_125 0.583 0.005 CID_66849195 | CID_66849195 | |
| 0.315 | 0.041 | 0.468 | Interleukin agonist | 0.285 0.056 CID_15361578 0.398 0.019 CID_125 0.468 0.011 CID_66849195 | CID_66849195 | |
| 0.276 | 0.005 | 0.276 | TRPA1 agonist | 0.185 0.014 CID_15361578 0.156 0.027 CID_125 0.169 0.02 CID_66849195 | ||
| 0.285 | 0.014 | 0.285 | NADPH oxidase inhibitor | 0.14 0.062 CID_15361578 0.247 0.021 CID_125 0.215 0.03 CID_66849195 | ||
| 0.275 | 0.008 | 0.275 | Farnesoid X receptor antagonist | 0.208 0.019 CID_15361578 0.224 0.016 CID_125 | ||
| 0.347 | 0.088 | 0.347 | Calpain 2 inhibitor | 0.289 0.122 CID_125 | ||
| 0.268 | 0.009 | 0.268 | GABA C receptor rho-2 antagonist | 0.207 0.025 CID_15361578 0.229 0.017 CID_125 | ||
| 0.278 | 0.019 | 0.278 | Heat shock protein 90 alpha antagonist | 0.151 0.086 CID_15361578 0.145 0.093 CID_125 | ||
| 0.267 | 0.01 | 0.432 | ATPase inhibitor | 0.289 0.007 CID_15361578 0.193 0.043 CID_125 0.432 0.003 CID_66849195 | CID_66849195 | |
| 0.353 | 0.1 | 0.667 | Antibacterial | 0.377 0.087 CID_15361578 0.375 0.088 CID_125 0.667 0.011 CID_66849195 | CID_66849195 | |
| 0.282 | 0.032 | 0.282 | Dual specificity phosphatase 3 inhibitor | 0.273 0.034 CID_125 | ||
| 0.256 | 0.008 | 0.475 | NADH dehydrogenase inhibitor | 0.191 0.011 CID_15361578 0.343 0.006 CID_125 0.475 0.004 CID_66849195 | CID_66849195 | |
| 0.251 | 0.005 | 0.251 | Macrophage migration inhibitory factor inhibitor | 0.244 0.005 CID_125 | ||
| 0.248 | 0.004 | 0.248 | Estrogen receptor beta agonist | 0.19 0.005 CID_125 0.04 0.021 CID_66849195 | ||
| 0.248 | 0.004 | 0.248 | Estrogen receptor alpha agonist | 0.191 0.005 CID_125 | ||
| 0.252 | 0.009 | 0.375 | Carbonic anhydrase VI inhibitor | 0.081 0.056 CID_15361578 0.375 0.004 CID_125 0.107 0.035 CID_66849195 | CID_125 | |
| 0.261 | 0.018 | 0.261 | Heat shock protein 90 antagonist | 0.188 0.044 CID_15361578 0.156 0.069 CID_125 | ||
| 0.256 | 0.015 | 0.256 | 5-Lipoxygenase inhibitor | 0.244 0.017 CID_125 | ||
| 0.246 | 0.005 | 0.309 | Keratolytic | 0.104 0.028 CID_15361578 0.309 0.004 CID_125 | CID_125 | |
| 0.27 | 0.034 | 0.27 | Dual specificity phosphatase inhibitor | 0.243 0.039 CID_125 | ||
| 0.284 | 0.048 | 0.438 | Cyclic AMP phosphodiesterase inhibitor | 0.321 0.034 CID_15361578 0.279 0.05 CID_125 0.438 0.012 CID_66849195 | CID_66849195 | |
| 0.243 | 0.008 | 0.243 | Alcohol dehydrogenase inhibitor | 0.111 0.041 CID_15361578 0.22 0.01 CID_125 0.173 0.015 CID_66849195 | ||
| 0.239 | 0.007 | 0.239 | GABA C receptor antagonist | 0.198 0.013 CID_15361578 0.198 0.013 CID_125 | ||
| 0.301 | 0.07 | 0.416 | Spasmolytic | 0.205 0.115 CID_15361578 0.356 0.051 CID_125 0.416 0.037 CID_66849195 | CID_66849195 | |
| 0.248 | 0.018 | 0.417 | Hexokinase inhibitor | 0.174 0.054 CID_15361578 0.27 0.014 CID_125 0.417 0.004 CID_66849195 | CID_66849195 | |
| 0.248 | 0.018 | 0.248 | Cholesterol synthesis inhibitor | 0.223 0.022 CID_15361578 0.2 0.027 CID_125 0.177 0.033 CID_66849195 | ||
| 0.233 | 0.004 | 0.233 | DOPA decarboxylase inhibitor | 0.157 0.018 CID_15361578 0.228 0.004 CID_125 | ||
| 0.308 | 0.08 | 0.563 | Apoptosis antagonist | 0.294 0.089 CID_15361578 0.44 0.029 CID_125 0.563 0.013 CID_66849195 | CID_66849195 | |
| 0.3 | 0.074 | 0.483 | Interleukin 2 agonist | 0.257 0.111 CID_15361578 0.467 0.013 CID_125 0.483 0.01 CID_66849195 | CID_66849195 | |
| 0.231 | 0.005 | 0.236 | Adenylate cyclase stimulant | 0.191 0.018 CID_15361578 0.236 0.005 CID_125 0.168 0.037 CID_66849195 | CID_125 | |
| 0.235 | 0.01 | 0.253 | Arachidonic acid antagonist | 0.253 0.005 CID_15361578 0.22 0.017 CID_125 0.191 0.042 CID_66849195 | CID_15361578 | |
| 0.236 | 0.012 | 0.278 | Toll-Like receptor 2 antagonist | 0.148 0.054 CID_15361578 0.278 0.006 CID_125 0.107 0.094 CID_66849195 | CID_125 | |
| 0.237 | 0.015 | 0.237 | Interleukin 4 antagonist | 0.109 0.102 CID_15361578 0.204 0.021 CID_125 0.173 0.033 CID_66849195 | ||
| 0.241 | 0.02 | 0.241 | 5 Hydroxytryptamine 3E antagonist | 0.236 0.023 CID_15361578 0.21 0.048 CID_125 | ||
| 0.24 | 0.022 | 0.248 | Alkaline phosphatase inhibitor | 0.171 0.047 CID_125 0.248 0.02 CID_66849195 | CID_66849195 | |
| 0.227 | 0.01 | 0.63 | Beta glucuronidase inhibitor | 0.121 0.045 CID_15361578 0.156 0.022 CID_125 0.63 0.003 CID_66849195 | CID_66849195 | |
| 0.238 | 0.023 | 0.238 | Neurotensin receptor agonist | 0.159 0.081 CID_15361578 0.209 0.03 CID_125 | ||
| 0.267 | 0.052 | 0.276 | Psychostimulant | 0.245 0.06 CID_15361578 0.236 0.064 CID_125 0.276 0.049 CID_66849195 | CID_66849195 | |
| 0.219 | 0.005 | 0.219 | Glutamate decarboxylase inhibitor | 0.141 0.015 CID_15361578 0.214 0.006 CID_125 | ||
| 0.26 | 0.047 | 0.26 | Neuropeptide Y2 antagonist | 0.195 0.129 CID_15361578 0.226 0.081 CID_125 | ||
| 0.22 | 0.008 | 0.296 | HIV-1 integrase (Overall Integration) inhibitor | 0.146 0.027 CID_15361578 0.296 0.004 CID_125 | CID_125 | |
| 0.241 | 0.031 | 0.253 | 3C-like protease (Human coronavirus) inhibitor | 0.253 0.026 CID_15361578 0.204 0.05 CID_125 | CID_15361578 | |
| 0.212 | 0.004 | 0.212 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.087 0.014 CID_15361578 0.161 0.005 CID_125 | ||
| 0.214 | 0.007 | 0.252 | Prolactin inhibitor | 0.14 0.027 CID_15361578 0.252 0.004 CID_125 | CID_125 | |
| 0.217 | 0.011 | 0.217 | 5 Hydroxytryptamine 3A agonist | 0.153 0.034 CID_15361578 0.119 0.057 CID_125 | ||
| 0.237 | 0.032 | 0.237 | Histone acetyltransferase inhibitor | 0.176 0.106 CID_15361578 0.187 0.089 CID_125 | ||
| 0.251 | 0.047 | 0.339 | DNA methyltransferase I inhibitor | 0.252 0.046 CID_125 0.339 0.016 CID_66849195 | CID_66849195 | |
| 0.343 | 0.141 | 0.343 | DNA directed DNA polymerase inhibitor | |||
| 0.214 | 0.012 | 0.312 | Carbonic anhydrase XIII inhibitor | 0.312 0.005 CID_125 0.22 0.011 CID_66849195 | CID_125 | |
| 0.294 | 0.092 | 0.718 | Antithrombotic | 0.26 0.118 CID_15361578 0.385 0.053 CID_125 0.718 0.007 CID_66849195 | CID_66849195 | |
| 0.302 | 0.101 | 0.302 | Thioredoxin glutathione reductase inhibitor | |||
| 0.209 | 0.009 | 0.263 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.114 0.031 CID_15361578 0.263 0.005 CID_125 | CID_125 | |
| 0.245 | 0.045 | 0.512 | Non-steroidal antiinflammatory agent | 0.163 0.101 CID_15361578 0.249 0.043 CID_125 0.512 0.006 CID_66849195 | CID_66849195 | |
| 0.24 | 0.04 | 0.26 | Insulin sensitizer | 0.189 0.085 CID_15361578 0.26 0.029 CID_125 0.236 0.043 CID_66849195 | CID_125 | |
| 0.203 | 0.003 | 0.203 | Ca2+-transporting ATPase inhibitor | 0.177 0.008 CID_15361578 0.187 0.005 CID_125 0.197 0.004 CID_66849195 | ||
| 0.21 | 0.011 | 0.31 | Photosensitizer | 0.222 0.009 CID_15361578 0.21 0.011 CID_125 0.31 0.004 CID_66849195 | CID_66849195 | |
| 0.205 | 0.005 | 0.214 | Heat shock protein 70 antagonist | 0.158 0.03 CID_15361578 0.193 0.008 CID_125 0.214 0.005 CID_66849195 | CID_66849195 | |
| 0.217 | 0.021 | 0.217 | Catenin beta inhibitor | 0.141 0.13 CID_15361578 | ||
| 0.199 | 0.003 | 0.199 | Estrogen-related receptor beta agonist | 0.106 0.018 CID_15361578 0.152 0.004 CID_125 | ||
| 0.209 | 0.013 | 0.209 | Potassium channel (Ca-activated) activator | 0.157 0.025 CID_125 | ||
| 0.217 | 0.024 | 0.217 | Death-associated protein kinase 2 inhibitor | |||
| 0.337 | 0.145 | 0.337 | DNA polymerase beta inhibitor | |||
| 0.244 | 0.053 | 0.517 | Nitric oxide antagonist | 0.279 0.045 CID_15361578 0.312 0.038 CID_125 0.517 0.015 CID_66849195 | CID_66849195 | |
| 0.201 | 0.011 | 0.201 | Sphingosine 1-phosphate receptor 5 antagonist | 0.158 0.049 CID_15361578 0.175 0.028 CID_125 | ||
| 0.196 | 0.006 | 0.196 | Biliverdin reductase inhibitor | 0.097 0.019 CID_15361578 0.165 0.008 CID_125 0.141 0.01 CID_66849195 | ||
| 0.205 | 0.017 | 0.559 | Cyclooxygenase 3 inhibitor | 0.173 0.032 CID_15361578 0.205 0.017 CID_125 0.559 0.003 CID_66849195 | CID_66849195 | |
| 0.223 | 0.035 | 0.258 | MAO inhibitor | 0.258 0.026 CID_125 | CID_125 | |
| 0.288 | 0.1 | 0.288 | Thyroid hormone antagonist | |||
| 0.195 | 0.009 | 0.195 | GABA C receptor rho-1 antagonist | 0.137 0.028 CID_15361578 0.166 0.016 CID_125 | ||
| 0.201 | 0.015 | 0.228 | Adenylate kinase inhibitor | 0.159 0.023 CID_15361578 0.228 0.012 CID_125 0.16 0.023 CID_66849195 | CID_125 | |
| 0.248 | 0.062 | 0.248 | Interleukin antagonist | 0.227 0.071 CID_125 | ||
| 0.196 | 0.013 | 0.196 | Vanilloid 1 agonist | 0.155 0.034 CID_15361578 0.196 0.013 CID_125 0.179 0.019 CID_66849195 | ||
| 0.192 | 0.01 | 0.192 | Sphingosine 1-phosphate receptor 2 antagonist | 0.136 0.062 CID_15361578 0.179 0.015 CID_125 | ||
| 0.226 | 0.044 | 0.226 | Mcl-1 antagonist | 0.125 0.119 CID_125 | ||
| 0.2 | 0.019 | 0.298 | Xanthine oxidase inhibitor | 0.085 0.082 CID_15361578 0.25 0.012 CID_125 0.298 0.008 CID_66849195 | CID_66849195 | |
| 0.191 | 0.011 | 0.191 | Sphingosine 1-phosphate receptor 4 antagonist | 0.142 0.041 CID_15361578 0.18 0.014 CID_125 | ||
| 0.192 | 0.012 | 0.192 | Papain-like protease (SARS coronavirus) inhibitor | 0.129 0.063 CID_15361578 0.133 0.055 CID_125 | ||
| 0.185 | 0.005 | 0.185 | GABA aminotransferase inhibitor | 0.128 0.013 CID_15361578 0.146 0.009 CID_125 0.162 0.006 CID_66849195 | ||
| 0.193 | 0.015 | 0.24 | Mucolytic | 0.154 0.03 CID_15361578 0.24 0.007 CID_125 0.204 0.012 CID_66849195 | CID_125 | |
| 0.206 | 0.028 | 0.211 | MAO A inhibitor | 0.083 0.078 CID_15361578 0.211 0.027 CID_125 | CID_125 | |
| 0.321 | 0.144 | 0.321 | Transcription factor inhibitor | |||
| 0.237 | 0.061 | 0.446 | Peptidyltransferase inhibitor | 0.183 0.123 CID_15361578 0.216 0.08 CID_125 0.446 0.005 CID_66849195 | CID_66849195 | |
| 0.196 | 0.021 | 0.525 | Expectorant | 0.129 0.045 CID_15361578 0.245 0.013 CID_125 0.525 0.003 CID_66849195 | CID_66849195 | |
| 0.253 | 0.079 | 0.33 | DNA damaging | 0.265 0.073 CID_15361578 0.33 0.047 CID_125 0.283 0.064 CID_66849195 | CID_125 | |
| 0.235 | 0.061 | 0.235 | MAP kinase kinase 2 inhibitor | 0.201 0.081 CID_125 | ||
| 0.215 | 0.041 | 0.215 | Cytidine deaminase inhibitor | 0.154 0.072 CID_15361578 0.188 0.053 CID_125 | ||
| 0.195 | 0.022 | 0.195 | Aminopeptidase B inhibitor | 0.135 0.044 CID_15361578 0.178 0.027 CID_125 | ||
| 0.232 | 0.059 | 0.349 | DNA methylase inhibitor | 0.249 0.049 CID_125 0.349 0.017 CID_66849195 | CID_66849195 | |
| 0.204 | 0.032 | 0.204 | Cyclooxygenase 1 inhibitor | 0.173 0.046 CID_125 0.115 0.085 CID_66849195 | ||
| 0.179 | 0.01 | 0.179 | Transcription factor STAT6 inhibitor | 0.137 0.035 CID_125 | ||
| 0.179 | 0.01 | 0.179 | CYP2A6 inhibitor | 0.119 0.027 CID_15361578 0.077 0.051 CID_125 | ||
| 0.172 | 0.004 | 0.172 | D-Ala-D-Ala ligase inhibitor | 0.099 0.031 CID_15361578 0.157 0.005 CID_125 | ||
| 0.192 | 0.025 | 0.192 | Cathepsin H inhibitor | 0.142 0.052 CID_15361578 0.165 0.037 CID_125 | ||
| 0.176 | 0.009 | 0.176 | Estrogen receptor alpha antagonist | 0.082 0.046 CID_15361578 0.126 0.017 CID_125 | ||
| 0.289 | 0.122 | 0.772 | Immunosuppressant | 0.772 0.004 CID_15361578 0.328 0.099 CID_125 0.556 0.019 CID_66849195 | CID_15361578 | |
| 0.179 | 0.013 | 0.307 | Phosphofructokinase-1 inhibitor | 0.137 0.021 CID_15361578 0.245 0.008 CID_125 0.307 0.005 CID_66849195 | CID_66849195 | |
| 0.196 | 0.031 | 0.39 | Cell wall synthesis inhibitor | 0.211 0.026 CID_15361578 0.235 0.019 CID_125 0.39 0.006 CID_66849195 | CID_66849195 | |
| 0.269 | 0.105 | 0.269 | Thyroid hormone beta antagonist | |||
| 0.172 | 0.008 | 0.174 | Interleukin 12 antagonist | 0.174 0.008 CID_125 0.162 0.009 CID_66849195 | CID_125 | |
| 0.196 | 0.033 | 0.196 | Anesthetic local | 0.127 0.062 CID_15361578 0.178 0.038 CID_125 | ||
| 0.188 | 0.027 | 0.277 | Chelator | 0.277 0.013 CID_125 | CID_125 | |
| 0.174 | 0.012 | 0.174 | Glutamate dehydrogenase inhibitor | 0.108 0.027 CID_15361578 0.171 0.013 CID_125 0.122 0.022 CID_66849195 | ||
| 0.238 | 0.077 | 0.238 | Calpain inhibitor | 0.166 0.155 CID_15361578 0.223 0.092 CID_125 | ||
| 0.237 | 0.076 | 0.838 | Angiogenesis stimulant | 0.168 0.112 CID_15361578 0.344 0.034 CID_125 0.838 0.003 CID_66849195 | CID_66849195 | |
| 0.237 | 0.077 | 0.331 | Antiamyloidogenic | 0.251 0.07 CID_125 0.331 0.043 CID_66849195 | CID_66849195 | |
| 0.174 | 0.014 | 0.174 | Urease inhibitor | 0.134 0.033 CID_125 | ||
| 0.169 | 0.01 | 0.178 | Anabolic | 0.178 0.008 CID_15361578 0.164 0.012 CID_125 0.113 0.047 CID_66849195 | CID_15361578 | |
| 0.182 | 0.025 | 0.235 | Microtubule formation inhibitor | 0.211 0.017 CID_15361578 0.163 0.032 CID_125 0.235 0.012 CID_66849195 | CID_66849195 | |
| 0.165 | 0.007 | 0.22 | Carbonic anhydrase VB inhibitor | 0.052 0.043 CID_15361578 0.22 0.004 CID_125 | CID_125 | |
| 0.162 | 0.005 | 0.162 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.054 0.047 CID_15361578 0.141 0.008 CID_125 0.16 0.006 CID_66849195 | ||
| 0.175 | 0.021 | 0.175 | Interleukin 8 antagonist | 0.149 0.035 CID_15361578 0.125 0.055 CID_125 | ||
| 0.176 | 0.022 | 0.178 | Pregnane X receptor agonist | 0.178 0.02 CID_15361578 0.149 0.055 CID_125 | CID_15361578 | |
| 0.212 | 0.058 | 0.212 | Sigma receptor agonist | 0.157 0.08 CID_15361578 | ||
| 0.203 | 0.052 | 0.203 | Tumour necrosis factor antagonist | 0.185 0.063 CID_125 | ||
| 0.162 | 0.012 | 0.209 | Carbonic anhydrase V inhibitor | 0.209 0.006 CID_125 | CID_125 | |
| 0.247 | 0.097 | 0.531 | Immunostimulant | 0.216 0.111 CID_15361578 0.347 0.065 CID_125 0.531 0.025 CID_66849195 | CID_66849195 | |
| 0.204 | 0.054 | 0.204 | Amyloid beta precursor protein antagonist | |||
| 0.155 | 0.006 | 0.166 | Purinergic P2X1 antagonist | 0.089 0.02 CID_15361578 0.166 0.005 CID_125 0.087 0.021 CID_66849195 | CID_125 | |
| 0.167 | 0.018 | 0.167 | Androgen antagonist | 0.148 0.023 CID_15361578 0.131 0.028 CID_125 | ||
| 0.193 | 0.045 | 0.299 | Interleukin 6 antagonist | 0.256 0.022 CID_15361578 0.299 0.015 CID_66849195 | CID_66849195 | |
| 0.177 | 0.029 | 0.209 | MAO B inhibitor | 0.209 0.023 CID_125 | CID_125 | |
| 0.153 | 0.006 | 0.155 | Glycine receptor agonist | 0.155 0.006 CID_15361578 0.123 0.012 CID_125 0.133 0.009 CID_66849195 | CID_15361578 | |
| 0.186 | 0.04 | 0.186 | Nav1.2 sodium channel blocker | 0.127 0.075 CID_125 | ||
| 0.177 | 0.031 | 0.213 | Adenylate cyclase inhibitor | 0.14 0.052 CID_15361578 0.213 0.023 CID_125 0.116 0.071 CID_66849195 | CID_125 | |
| 0.16 | 0.016 | 0.16 | Electrolyte absorption antagonist | 0.124 0.033 CID_15361578 0.122 0.035 CID_125 | ||
| 0.159 | 0.015 | 0.159 | NMDA 2 receptor antagonist | 0.095 0.035 CID_125 | ||
| 0.148 | 0.004 | 0.148 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.096 0.005 CID_125 | ||
| 0.145 | 0.003 | 0.145 | Dopamine D5 agonist | 0.06 0.012 CID_15361578 0.106 0.004 CID_125 | ||
| 0.215 | 0.074 | 0.215 | ErbB-1 antagonist | 0.172 0.129 CID_125 | ||
| 0.144 | 0.005 | 0.144 | GABA B receptor agonist | 0.084 0.034 CID_15361578 0.129 0.005 CID_125 | ||
| 0.145 | 0.006 | 0.145 | Estradiol 17 beta-dehydrogenase inhibitor | 0.047 0.026 CID_15361578 0.112 0.009 CID_125 | ||
| 0.188 | 0.049 | 0.199 | Phospholipase A2 inhibitor | 0.199 0.043 CID_125 0.158 0.067 CID_66849195 | CID_125 | |
| 0.149 | 0.01 | 0.231 | Glutamate release inhibitor | 0.128 0.017 CID_15361578 0.231 0.004 CID_125 0.162 0.007 CID_66849195 | CID_125 | |
| 0.142 | 0.004 | 0.142 | CC chemokine 5 receptor agonist | 0.094 0.029 CID_15361578 0.099 0.023 CID_125 | ||
| 0.171 | 0.034 | 0.171 | Nav1.6 sodium channel blocker | 0.113 0.108 CID_15361578 0.156 0.047 CID_125 | ||
| 0.149 | 0.014 | 0.149 | HIV-1 integrase (3'-Processing) inhibitor | 0.126 0.018 CID_125 0.07 0.039 CID_66849195 | ||
| 0.146 | 0.012 | 0.173 | Carbonic anhydrase VA inhibitor | 0.173 0.007 CID_125 | CID_125 | |
| 0.143 | 0.009 | 0.143 | Bile acid receptor antagonist | 0.119 0.02 CID_15361578 0.131 0.013 CID_125 0.104 0.041 CID_66849195 | ||
| 0.146 | 0.013 | 0.16 | Lanosterol 14 alpha demethylase inhibitor | 0.135 0.018 CID_15361578 0.16 0.008 CID_125 | CID_125 | |
| 0.146 | 0.013 | 0.146 | Aminopeptidase I inhibitor | 0.095 0.031 CID_15361578 0.12 0.019 CID_125 | ||
| 0.139 | 0.007 | 0.182 | Granulocyte macrophage colony stimulating factor agonist | 0.109 0.025 CID_15361578 0.182 0.004 CID_125 | CID_125 | |
| 0.17 | 0.039 | 0.17 | Neuropeptide Y1 antagonist | 0.129 0.102 CID_15361578 0.146 0.071 CID_125 | ||
| 0.146 | 0.015 | 0.146 | Histamine N-methyltransferase inhibitor | 0.079 0.068 CID_15361578 0.104 0.042 CID_125 | ||
| 0.196 | 0.067 | 0.568 | Hepatoprotectant | 0.165 0.095 CID_15361578 0.296 0.031 CID_125 0.568 0.005 CID_66849195 | CID_66849195 | |
| 0.199 | 0.072 | 0.492 | Platelet adhesion inhibitor | 0.224 0.059 CID_125 0.492 0.005 CID_66849195 | CID_66849195 | |
| 0.322 | 0.195 | 0.822 | Antiinflammatory | 0.519 0.08 CID_15361578 0.519 0.08 CID_125 0.822 0.013 CID_66849195 | CID_66849195 | |
| 0.149 | 0.023 | 0.17 | CC chemokine 6 receptor antagonist | 0.126 0.088 CID_125 0.17 0.008 CID_66849195 | CID_66849195 | |
| 0.163 | 0.037 | 0.163 | Antibacterial (Helicobacter pylori) | 0.118 0.085 CID_15361578 0.162 0.037 CID_125 | ||
| 0.15 | 0.024 | 0.15 | NMDA receptor antagonist | 0.106 0.043 CID_125 | ||
| 0.129 | 0.004 | 0.129 | Glutamate (mGluR7) antagonist | 0.105 0.008 CID_15361578 0.102 0.009 CID_125 | ||
| 0.164 | 0.04 | 0.164 | MAP kinase kinase 4 inhibitor | 0.138 0.088 CID_15361578 0.155 0.053 CID_125 | ||
| 0.197 | 0.074 | 0.215 | I kappa B kinase epsilon inhibitor | 0.143 0.127 CID_15361578 0.215 0.059 CID_125 | CID_125 | |
| 0.166 | 0.043 | 0.315 | Topoisomerase II inhibitor | 0.247 0.025 CID_125 0.315 0.016 CID_66849195 | CID_66849195 | |
| 0.126 | 0.004 | 0.128 | MAP kinase kinase 7 inhibitor | 0.099 0.014 CID_15361578 0.128 0.004 CID_125 | CID_125 | |
| 0.133 | 0.012 | 0.134 | Sphingosine 1-phosphate receptor 4 agonist | 0.134 0.012 CID_125 | CID_125 | |
| 0.177 | 0.058 | 0.259 | Protein-tyrosine phosphatase inhibitor | 0.259 0.029 CID_125 0.168 0.063 CID_66849195 | CID_125 | |
| 0.146 | 0.027 | 0.146 | Opioid antagonist | 0.101 0.047 CID_125 | ||
| 0.164 | 0.048 | 0.164 | M17 leucyl aminopeptidase inhibitor | |||
| 0.132 | 0.016 | 0.201 | Phosphodiesterase 6D inhibitor | 0.122 0.023 CID_125 0.201 0.004 CID_66849195 | CID_66849195 | |
| 0.146 | 0.031 | 0.432 | AMP-activated protein kinase stimulant | 0.174 0.016 CID_125 0.432 0.004 CID_66849195 | CID_66849195 | |
| 0.148 | 0.033 | 0.298 | DNA repair enzyme inhibitor | 0.121 0.07 CID_15361578 0.174 0.016 CID_125 0.298 0.004 CID_66849195 | CID_66849195 | |
| 0.121 | 0.006 | 0.121 | Heat shock protein 90 beta antagonist | 0.061 0.038 CID_15361578 0.064 0.034 CID_125 | ||
| 0.124 | 0.01 | 0.124 | NMDA 2C receptor antagonist | 0.058 0.048 CID_15361578 0.069 0.034 CID_125 | ||
| 0.125 | 0.011 | 0.125 | NMDA 2B receptor antagonist | 0.066 0.027 CID_125 | ||
| 0.15 | 0.037 | 0.16 | Falcipain 3 inhibitor | 0.111 0.06 CID_15361578 0.16 0.032 CID_125 | CID_125 | |
| 0.127 | 0.014 | 0.133 | Argininosuccinate synthase inhibitor | 0.108 0.017 CID_15361578 0.133 0.013 CID_125 0.087 0.023 CID_66849195 | CID_125 | |
| 0.118 | 0.006 | 0.118 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.12 | 0.009 | 0.12 | NMDA receptor subunit 3B antagonist | 0.065 0.017 CID_125 | ||
| 0.164 | 0.053 | 0.488 | Hemostatic | 0.201 0.032 CID_125 0.488 0.005 CID_66849195 | CID_66849195 | |
| 0.125 | 0.015 | 0.125 | Potassium channel large-conductance Ca-activated activator | 0.085 0.032 CID_125 | ||
| 0.129 | 0.02 | 0.144 | Ornithine decarboxylase inhibitor | 0.105 0.04 CID_15361578 0.144 0.013 CID_125 0.108 0.036 CID_66849195 | CID_125 | |
| 0.142 | 0.033 | 0.385 | Mediator release inhibitor | 0.147 0.03 CID_125 0.385 0.005 CID_66849195 | CID_66849195 | |
| 0.155 | 0.046 | 0.191 | DNA polymerase I inhibitor | 0.191 0.031 CID_125 0.179 0.035 CID_66849195 | CID_125 | |
| 0.16 | 0.052 | 0.484 | Bone formation stimulant | 0.484 0.006 CID_15361578 0.171 0.046 CID_125 0.122 0.084 CID_66849195 | CID_15361578 | |
| 0.127 | 0.019 | 0.127 | Glutathione S-transferase inhibitor | 0.089 0.049 CID_15361578 0.118 0.024 CID_125 0.075 0.07 CID_66849195 | ||
| 0.129 | 0.022 | 0.213 | Adrenaline agonist | 0.213 0.006 CID_125 | CID_125 | |
| 0.123 | 0.016 | 0.175 | Glycine receptor antagonist | 0.131 0.013 CID_15361578 0.102 0.031 CID_125 0.175 0.004 CID_66849195 | CID_66849195 | |
| 0.136 | 0.029 | 0.186 | Catalase inhibitor | 0.063 0.062 CID_15361578 0.186 0.018 CID_125 | CID_125 | |
| 0.13 | 0.023 | 0.13 | Opioid delta receptor antagonist | 0.075 0.038 CID_125 | ||
| 0.165 | 0.059 | 0.165 | Cyclooxygenase inhibitor | 0.126 0.092 CID_125 | ||
| 0.121 | 0.015 | 0.153 | Carbamoyl phosphate synthetase inhibitor | 0.092 0.023 CID_15361578 0.153 0.011 CID_125 0.07 0.034 CID_66849195 | CID_125 | |
| 0.11 | 0.004 | 0.11 | Dihydroorotate oxidase inhibitor | 0.087 0.008 CID_15361578 0.078 0.011 CID_125 | ||
| 0.135 | 0.03 | 0.212 | Uric acid excretion stimulant | 0.212 0.011 CID_125 0.188 0.015 CID_66849195 | CID_125 | |
| 0.13 | 0.025 | 0.162 | Thioredoxin inhibitor | 0.137 0.022 CID_15361578 0.139 0.021 CID_125 0.162 0.014 CID_66849195 | CID_66849195 | |
| 0.165 | 0.06 | 0.396 | Insulin secretagoues | 0.168 0.057 CID_125 0.396 0.006 CID_66849195 | CID_66849195 | |
| 0.12 | 0.015 | 0.121 | HIV-1 integrase inhibitor | 0.121 0.015 CID_125 | CID_125 | |
| 0.107 | 0.004 | 0.107 | Glutamate (mGluR1a) agonist | 0.034 0.007 CID_15361578 0.028 0.01 CID_125 | ||
| 0.107 | 0.004 | 0.107 | Adenylate cyclase 1 inhibitor | 0.079 0.008 CID_15361578 0.057 0.02 CID_125 | ||
| 0.12 | 0.017 | 0.12 | HIV-1 integrase (Strand Transfer) inhibitor | 0.108 0.02 CID_125 0.064 0.039 CID_66849195 | ||
| 0.133 | 0.03 | 0.142 | Acetylcholine release stimulant | 0.13 0.034 CID_15361578 0.124 0.043 CID_125 0.142 0.022 CID_66849195 | CID_66849195 | |
| 0.121 | 0.019 | 0.158 | Myeloperoxidase inhibitor | 0.158 0.009 CID_125 | CID_125 | |
| 0.115 | 0.013 | 0.136 | Acyl-CoA dehydrogenase inhibitor | 0.083 0.021 CID_15361578 0.136 0.01 CID_125 0.061 0.032 CID_66849195 | CID_125 | |
| 0.109 | 0.008 | 0.116 | Glutamate (mGluR6) antagonist | 0.116 0.006 CID_15361578 0.108 0.008 CID_125 0.075 0.031 CID_66849195 | CID_15361578 | |
| 0.113 | 0.012 | 0.166 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.072 0.024 CID_15361578 0.166 0.008 CID_125 0.135 0.01 CID_66849195 | CID_125 | |
| 0.135 | 0.034 | 0.135 | Gastric antisecretory | 0.118 0.044 CID_125 | ||
| 0.112 | 0.011 | 0.115 | Androgen agonist | 0.115 0.011 CID_15361578 0.099 0.015 CID_125 | CID_15361578 | |
| 0.105 | 0.005 | 0.105 | Transcription factor RelA inhibitor | 0.076 0.021 CID_15361578 0.067 0.036 CID_125 | ||
| 0.148 | 0.048 | 0.29 | Alkylator | 0.15 0.047 CID_15361578 0.22 0.021 CID_125 0.29 0.013 CID_66849195 | CID_66849195 | |
| 0.107 | 0.007 | 0.11 | Aconitate hydratase inhibitor | 0.103 0.008 CID_15361578 0.11 0.007 CID_125 | CID_125 | |
| 0.125 | 0.026 | 0.157 | Cathepsin G inhibitor | 0.157 0.02 CID_125 | CID_125 | |
| 0.122 | 0.023 | 0.122 | Opioid kappa receptor antagonist | 0.073 0.069 CID_15361578 0.087 0.049 CID_125 | ||
| 0.112 | 0.013 | 0.168 | Xanthine dehydrogenase inhibitor | 0.168 0.005 CID_125 0.052 0.044 CID_66849195 | CID_125 | |
| 0.101 | 0.003 | 0.101 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.051 0.013 CID_15361578 0.079 0.004 CID_125 | ||
| 0.147 | 0.048 | 0.147 | Proteasome inhibitor | 0.13 0.058 CID_15361578 0.145 0.05 CID_125 | ||
| 0.171 | 0.073 | 0.205 | Antipruritic | 0.205 0.046 CID_15361578 | CID_15361578 | |
| 0.122 | 0.024 | 0.122 | Inducible nitric-oxide synthase inhibitor | 0.11 0.029 CID_15361578 0.08 0.062 CID_125 | ||
| 0.174 | 0.077 | 0.174 | LIM domain kinase 1 inhibitor | |||
| 0.121 | 0.024 | 0.121 | Opioid mu receptor antagonist | 0.077 0.042 CID_125 | ||
| 0.116 | 0.02 | 0.117 | Vanilloid agonist | 0.081 0.068 CID_15361578 0.117 0.02 CID_125 | CID_125 | |
| 0.108 | 0.014 | 0.108 | Alpha tubulin antagonist | 0.051 0.039 CID_125 | ||
| 0.113 | 0.021 | 0.132 | Na+ K+ transporting ATPase inhibitor | 0.113 0.021 CID_15361578 0.12 0.016 CID_125 0.132 0.011 CID_66849195 | CID_66849195 | |
| 0.097 | 0.005 | 0.097 | Adenine nucleotide translocase inhibitor | 0.081 0.009 CID_125 0.097 0.005 CID_66849195 | ||
| 0.105 | 0.014 | 0.105 | Potassium channel (ATP-sensitive) blocker | 0.083 0.026 CID_125 | ||
| 0.115 | 0.024 | 0.282 | ATPase (Vacuolar H+) inhibitor | 0.282 0.001 CID_15361578 0.146 0.009 CID_66849195 | CID_15361578 | |
| 0.099 | 0.008 | 0.147 | Sphingosine kinase 2 inhibitor | 0.147 0.004 CID_125 | CID_125 | |
| 0.105 | 0.015 | 0.105 | Maillard reaction inhibitor | 0.101 0.016 CID_125 | ||
| 0.104 | 0.014 | 0.115 | Beta 3 adrenoreceptor antagonist | 0.115 0.011 CID_125 | CID_125 | |
| 0.095 | 0.005 | 0.095 | Ryanodine receptor antagonist | 0.082 0.008 CID_15361578 0.08 0.009 CID_125 | ||
| 0.098 | 0.009 | 0.098 | NMDA receptor subunit 3A antagonist | 0.055 0.018 CID_125 | ||
| 0.133 | 0.043 | 0.139 | Caspase 3 inhibitor | 0.119 0.062 CID_15361578 0.139 0.037 CID_125 | CID_125 | |
| 0.093 | 0.004 | 0.093 | Pregnane X receptor antagonist | 0.088 0.005 CID_15361578 0.066 0.019 CID_125 | ||
| 0.159 | 0.07 | 0.336 | Diuretic | 0.13 0.094 CID_15361578 0.336 0.018 CID_66849195 | CID_66849195 | |
| 0.115 | 0.026 | 0.115 | Bromodomain-containing protein 2 inhibitor | 0.088 0.06 CID_15361578 0.09 0.055 CID_125 | ||
| 0.126 | 0.038 | 0.19 | Toll-Like receptor 4 antagonist | 0.09 0.089 CID_15361578 0.154 0.019 CID_125 0.19 0.008 CID_66849195 | CID_66849195 | |
| 0.121 | 0.034 | 0.122 | MAP kinase kinase 1 inhibitor | 0.122 0.033 CID_15361578 0.111 0.044 CID_125 | CID_15361578 | |
| 0.111 | 0.023 | 0.127 | mTOR complex 2 inhibitor | 0.12 0.017 CID_15361578 0.127 0.014 CID_125 | CID_125 | |
| 0.118 | 0.031 | 0.217 | Topoisomerase II alpha inhibitor | 0.144 0.024 CID_125 0.217 0.013 CID_66849195 | CID_66849195 | |
| 0.131 | 0.044 | 0.168 | Protein kinase C gamma inhibitor | 0.168 0.023 CID_125 | CID_125 | |
| 0.107 | 0.02 | 0.107 | Aromatase inhibitor | 0.106 0.02 CID_15361578 0.099 0.022 CID_125 | ||
| 0.09 | 0.003 | 0.09 | Estrogen-related receptor beta antagonist | 0.067 0.004 CID_125 | ||
| 0.094 | 0.007 | 0.094 | Calcium channel P-type blocker | 0.077 0.018 CID_15361578 0.069 0.03 CID_125 | ||
| 0.137 | 0.051 | 0.161 | Beta amyloid protein antagonist | 0.098 0.092 CID_15361578 0.113 0.074 CID_125 0.161 0.033 CID_66849195 | CID_66849195 | |
| 0.092 | 0.006 | 0.092 | Squalene epoxidase inhibitor | 0.073 0.013 CID_15361578 0.09 0.007 CID_125 0.047 0.039 CID_66849195 | ||
| 0.108 | 0.024 | 0.109 | CDC25A inhibitor | 0.073 0.053 CID_15361578 0.109 0.023 CID_125 | CID_125 | |
| 0.088 | 0.004 | 0.088 | Alpha 1d adrenoreceptor agonist | 0.041 0.025 CID_15361578 0.046 0.02 CID_125 | ||
| 0.087 | 0.004 | 0.087 | Dopamine beta hydroxylase inhibitor | 0.049 0.032 CID_15361578 0.084 0.005 CID_125 | ||
| 0.086 | 0.005 | 0.086 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.052 0.011 CID_15361578 0.062 0.008 CID_125 | ||
| 0.092 | 0.01 | 0.183 | Topoisomerase II beta inhibitor | 0.053 0.029 CID_15361578 0.183 0.004 CID_125 0.063 0.02 CID_66849195 | CID_125 | |
| 0.086 | 0.004 | 0.086 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.059 0.005 CID_125 | ||
| 0.118 | 0.037 | 0.137 | Interleukin 1 beta converting enzyme inhibitor | 0.098 0.06 CID_15361578 0.137 0.024 CID_125 | CID_125 | |
| 0.088 | 0.007 | 0.134 | Glucose-6-phosphate isomerase inhibitor | 0.071 0.012 CID_15361578 0.115 0.004 CID_125 0.134 0.003 CID_66849195 | CID_66849195 | |
| 0.096 | 0.016 | 0.096 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.076 0.046 CID_15361578 0.075 0.047 CID_125 | ||
| 0.102 | 0.022 | 0.102 | Beta tubulin antagonist | |||
| 0.094 | 0.015 | 0.094 | NMDA 2A receptor antagonist | 0.055 0.033 CID_125 | ||
| 0.128 | 0.051 | 0.283 | Topoisomerase I inhibitor | 0.273 0.014 CID_125 0.283 0.012 CID_66849195 | CID_66849195 | |
| 0.117 | 0.04 | 0.117 | Nitric-oxide synthase inhibitor | 0.101 0.058 CID_15361578 0.09 0.077 CID_125 | ||
| 0.095 | 0.018 | 0.095 | Phospholipase D inhibitor | 0.074 0.046 CID_15361578 0.079 0.036 CID_125 | ||
| 0.09 | 0.014 | 0.09 | Fatty acid synthase inhibitor | 0.06 0.035 CID_15361578 0.066 0.029 CID_125 | ||
| 0.093 | 0.018 | 0.093 | 5 Hydroxytryptamine 2A agonist | 0.071 0.036 CID_15361578 0.077 0.03 CID_125 | ||
| 0.095 | 0.019 | 0.095 | NMDA receptor glycine site agonist | 0.076 0.032 CID_15361578 0.066 0.04 CID_125 | ||
| 0.139 | 0.064 | 0.139 | Tubulin antagonist | |||
| 0.094 | 0.019 | 0.113 | Beta adrenoreceptor antagonist | 0.113 0.012 CID_125 | CID_125 | |
| 0.095 | 0.021 | 0.095 | NMDA receptor agonist | 0.082 0.028 CID_15361578 0.071 0.035 CID_125 | ||
| 0.078 | 0.004 | 0.078 | ATP citrate lysase inhibitor | 0.037 0.015 CID_15361578 0.054 0.007 CID_125 | ||
| 0.086 | 0.013 | 0.122 | Sphingosine kinase inhibitor | 0.122 0.005 CID_125 | CID_125 | |
| 0.085 | 0.012 | 0.085 | Heme oxygenase stimulant | 0.061 0.042 CID_15361578 0.059 0.05 CID_125 0.057 0.054 CID_66849195 | ||
| 0.138 | 0.065 | 0.154 | Toll-Like receptor antagonist | 0.117 0.089 CID_15361578 0.154 0.053 CID_125 | CID_125 | |
| 0.111 | 0.039 | 0.145 | Protein kinase C zeta inhibitor | 0.145 0.021 CID_125 | CID_125 | |
| 0.129 | 0.057 | 0.204 | Protein-tyrosine phosphatase 1B inhibitor | 0.204 0.028 CID_125 0.161 0.041 CID_66849195 | CID_125 | |
| 0.141 | 0.069 | 0.141 | Toll-Like receptor 9 antagonist | 0.124 0.082 CID_15361578 | ||
| 0.076 | 0.004 | 0.08 | Guanylate cyclase inhibitor | 0.067 0.006 CID_15361578 0.076 0.004 CID_125 0.08 0.003 CID_66849195 | CID_66849195 | |
| 0.087 | 0.014 | 0.124 | Carbonic anhydrase XIV inhibitor | 0.121 0.007 CID_125 0.124 0.006 CID_66849195 | CID_66849195 | |
| 0.1 | 0.028 | 0.157 | Thioredoxin reductase inhibitor | 0.157 0.008 CID_15361578 0.113 0.02 CID_125 | CID_15361578 | |
| 0.187 | 0.115 | 0.399 | Vasodilator | 0.269 0.06 CID_125 0.399 0.023 CID_66849195 | CID_66849195 | |
| 0.148 | 0.076 | 0.148 | Acetylcholine M1 receptor antagonist | 0.117 0.113 CID_15361578 0.146 0.078 CID_125 | ||
| 0.09 | 0.019 | 0.09 | Aryl hydrocarbon receptor antagonist | 0.066 0.043 CID_125 | ||
| 0.11 | 0.039 | 0.11 | Potassium channel activator | |||
| 0.088 | 0.017 | 0.118 | Exportin-1 inhibitor | 0.118 0.005 CID_15361578 0.073 0.036 CID_125 | CID_15361578 | |
| 0.161 | 0.091 | 0.203 | Lipocortins synthesis antagonist | 0.203 0.054 CID_15361578 0.155 0.098 CID_66849195 | CID_15361578 | |
| 0.115 | 0.045 | 0.174 | Sphingomyelinase inhibitor | 0.104 0.055 CID_15361578 0.174 0.016 CID_125 0.105 0.054 CID_66849195 | CID_125 | |
| 0.093 | 0.023 | 0.103 | Vanilloid 4 agonist | 0.103 0.015 CID_15361578 0.097 0.019 CID_125 | CID_15361578 | |
| 0.083 | 0.014 | 0.126 | Glucosylceramidase inhibitor | 0.126 0.005 CID_125 0.056 0.037 CID_66849195 | CID_125 | |
| 0.153 | 0.085 | 0.231 | Growth hormone agonist | 0.231 0.048 CID_125 | CID_125 | |
| 0.074 | 0.008 | 0.074 | Nicotinic acid receptor agonist | 0.044 0.017 CID_15361578 0.06 0.011 CID_125 | ||
| 0.144 | 0.077 | 0.148 | MAP kinase 3 inhibitor | 0.148 0.07 CID_125 | CID_125 | |
| 0.073 | 0.006 | 0.073 | Geranyltranstransferase inhibitor | 0.053 0.02 CID_15361578 0.055 0.018 CID_125 | ||
| 0.074 | 0.008 | 0.074 | Dihydropteroate synthase inhibitor | 0.061 0.011 CID_125 | ||
| 0.097 | 0.031 | 0.097 | Purinergic P2X2 antagonist | |||
| 0.074 | 0.008 | 0.074 | Retinoid X alpha receptor agonist | 0.041 0.019 CID_15361578 0.054 0.013 CID_125 | ||
| 0.091 | 0.026 | 0.102 | Acetylcholine M5 receptor agonist | 0.102 0.019 CID_15361578 | CID_15361578 | |
| 0.13 | 0.065 | 0.13 | MAP kinase kinase inhibitor | 0.123 0.071 CID_125 | ||
| 0.081 | 0.017 | 0.09 | Beta 1 adrenoreceptor antagonist | 0.09 0.013 CID_125 | CID_125 | |
| 0.066 | 0.002 | 0.066 | Estrogen-related receptor gamma antagonist | 0.027 0.024 CID_15361578 0.053 0.003 CID_125 | ||
| 0.086 | 0.022 | 0.086 | 5 Hydroxytryptamine 3 agonist | 0.058 0.053 CID_125 | ||
| 0.107 | 0.043 | 0.111 | Antineoplastic alkaloid | 0.11 0.042 CID_15361578 0.111 0.041 CID_125 | CID_125 | |
| 0.076 | 0.012 | 0.109 | Beta 2 adrenoreceptor agonist | 0.109 0.004 CID_125 | CID_125 | |
| 0.08 | 0.017 | 0.08 | Botulinum neurotoxin type A inhibitor | 0.054 0.047 CID_15361578 0.056 0.044 CID_125 | ||
| 0.106 | 0.043 | 0.106 | ABCA1 expression enhancer | 0.091 0.064 CID_15361578 0.089 0.068 CID_125 | ||
| 0.091 | 0.029 | 0.094 | Sphingosine 1-phosphate receptor antagonist | 0.094 0.026 CID_125 | CID_125 | |
| 0.077 | 0.014 | 0.077 | 5 Hydroxytryptamine 7 agonist | |||
| 0.085 | 0.024 | 0.099 | CDC25B inhibitor | 0.099 0.016 CID_125 | CID_125 | |
| 0.084 | 0.023 | 0.084 | TRPA1 antagonist | |||
| 0.075 | 0.014 | 0.075 | Carbonic anhydrase VII inhibitor | 0.043 0.036 CID_15361578 0.069 0.016 CID_125 | ||
| 0.071 | 0.01 | 0.071 | Retinoid X receptor agonist | 0.044 0.02 CID_15361578 0.052 0.017 CID_125 | ||
| 0.079 | 0.018 | 0.079 | Dihydroorotate dehydrogenase inhibitor | 0.064 0.025 CID_125 | ||
| 0.075 | 0.014 | 0.083 | Beta 2 adrenoreceptor antagonist | 0.083 0.011 CID_125 | CID_125 | |
| 0.107 | 0.047 | 0.119 | Glutamate (mGluR7) agonist | 0.119 0.031 CID_15361578 0.105 0.051 CID_125 | CID_15361578 | |
| 0.073 | 0.015 | 0.207 | Alpha-mannosidase inhibitor | 0.058 0.029 CID_15361578 0.119 0.005 CID_125 0.207 0.003 CID_66849195 | CID_66849195 | |
| 0.074 | 0.015 | 0.074 | Nicotinic alpha3beta2 receptor antagonist | 0.064 0.022 CID_15361578 0.053 0.038 CID_125 | ||
| 0.063 | 0.005 | 0.078 | Uridine phosphorylase inhibitor | 0.03 0.018 CID_15361578 0.078 0.004 CID_125 0.078 0.004 CID_66849195 | CID_66849195 | |
| 0.07 | 0.012 | 0.07 | Dihydroorotase inhibitor | |||
| 0.093 | 0.035 | 0.131 | Interferon agonist | 0.082 0.049 CID_15361578 0.131 0.014 CID_125 0.123 0.016 CID_66849195 | CID_125 | |
| 0.072 | 0.014 | 0.072 | Potassium channel Kv1.3 blocker | 0.046 0.034 CID_15361578 0.056 0.024 CID_125 | ||
| 0.076 | 0.02 | 0.086 | Sphingosine 1-phosphate receptor 3 antagonist | 0.086 0.014 CID_125 | CID_125 | |
| 0.08 | 0.024 | 0.08 | Alpha 2 adrenoreceptor agonist | 0.063 0.039 CID_125 | ||
| 0.082 | 0.027 | 0.096 | Protein kinase C beta inhibitor | 0.096 0.015 CID_125 | CID_125 | |
| 0.066 | 0.011 | 0.066 | Purinergic P2X4 antagonist | 0.064 0.012 CID_125 | ||
| 0.091 | 0.036 | 0.091 | Analgesic, opioid | |||
| 0.078 | 0.024 | 0.114 | Aldose reductase inhibitor | 0.077 0.024 CID_125 0.114 0.015 CID_66849195 | CID_66849195 | |
| 0.067 | 0.014 | 0.067 | Immunoglobulin Fc receptor antagonist | 0.055 0.037 CID_15361578 0.067 0.014 CID_125 | ||
| 0.08 | 0.027 | 0.09 | Protease 3C (Human rhinovirus) inhibitor | 0.078 0.028 CID_15361578 0.09 0.02 CID_125 | CID_125 | |
| 0.065 | 0.012 | 0.065 | Urate transporter 1 inhibitor | 0.052 0.018 CID_125 | ||
| 0.066 | 0.013 | 0.066 | Oxytocin agonist | 0.04 0.032 CID_15361578 0.059 0.018 CID_125 | ||
| 0.072 | 0.019 | 0.072 | Opioid mu receptor agonist | 0.048 0.031 CID_125 | ||
| 0.075 | 0.023 | 0.076 | Cyclin D1 inhibitor | 0.076 0.021 CID_125 | CID_125 | |
| 0.114 | 0.062 | 0.114 | Nav1.5 sodium channel blocker | 0.101 0.083 CID_125 | ||
| 0.057 | 0.005 | 0.143 | Sodium/glucose cotransporter 2 inhibitor | 0.09 0.003 CID_125 0.143 0.002 CID_66849195 | CID_66849195 | |
| 0.067 | 0.015 | 0.067 | CXC chemokine 1 receptor antagonist | 0.057 0.026 CID_125 | ||
| 0.056 | 0.004 | 0.056 | Glutamate (mGluR3) agonist | 0.045 0.007 CID_15361578 0.051 0.005 CID_125 0.031 0.026 CID_66849195 | ||
| 0.066 | 0.014 | 0.066 | Fructose-1,6-bisphosphatase inhibitor | 0.041 0.038 CID_125 | ||
| 0.059 | 0.007 | 0.063 | Glutamate (mGluR8) agonist | 0.062 0.006 CID_15361578 0.063 0.006 CID_125 | CID_125 | |
| 0.059 | 0.007 | 0.059 | Kainate receptor agonist | 0.059 0.007 CID_15361578 0.053 0.011 CID_125 | ||
| 0.056 | 0.005 | 0.067 | CF transmembrane conductance regulator antagonist | 0.067 0.004 CID_125 | CID_125 | |
| 0.068 | 0.016 | 0.073 | Leukotriene C antagonist | 0.054 0.048 CID_15361578 0.073 0.012 CID_125 | CID_125 | |
| 0.063 | 0.012 | 0.063 | Glutamate (mGluR group III) antagonist | 0.06 0.013 CID_15361578 0.046 0.026 CID_125 | ||
| 0.111 | 0.061 | 0.111 | Electron transport complex I inhibitor | |||
| 0.125 | 0.075 | 0.125 | Cyclooxygenase 2 inhibitor | |||
| 0.071 | 0.02 | 0.075 | Glycine transporter 2 inhibitor | 0.075 0.019 CID_125 | CID_125 | |
| 0.057 | 0.007 | 0.057 | Catechol O-methyltransferase inhibitor | 0.045 0.01 CID_125 | ||
| 0.055 | 0.005 | 0.055 | Vanilloid 3 antagonist | 0.045 0.014 CID_15361578 0.043 0.017 CID_125 | ||
| 0.111 | 0.061 | 0.148 | Nav1.4 sodium channel blocker | 0.148 0.035 CID_125 | CID_125 | |
| 0.061 | 0.012 | 0.099 | Liver X receptor alpha agonist | 0.099 0.005 CID_125 | CID_125 | |
| 0.077 | 0.027 | 0.106 | Interferon inducer | 0.067 0.04 CID_15361578 0.106 0.01 CID_125 0.099 0.013 CID_66849195 | CID_125 | |
| 0.066 | 0.017 | 0.071 | Lysophosphatidic acid 3 receptor antagonist | 0.046 0.043 CID_15361578 0.071 0.013 CID_125 | CID_125 | |
| 0.076 | 0.026 | 0.085 | MDM2 inhibitor | 0.085 0.015 CID_125 | CID_125 | |
| 0.056 | 0.007 | 0.056 | Free fatty acid receptor 1 antagonist | 0.043 0.013 CID_15361578 0.053 0.008 CID_125 | ||
| 0.059 | 0.01 | 0.061 | GABA uptake inhibitor | 0.044 0.021 CID_15361578 0.061 0.01 CID_125 | CID_125 | |
| 0.081 | 0.032 | 0.081 | Peroxisome proliferator-activated receptor gamma antagonist | 0.076 0.041 CID_125 | ||
| 0.058 | 0.009 | 0.071 | Glutamate (mGluR3) antagonist | 0.046 0.015 CID_15361578 0.071 0.006 CID_125 | CID_125 | |
| 0.081 | 0.032 | 0.081 | Dopamine D1 antagonist | 0.061 0.048 CID_125 | ||
| 0.066 | 0.017 | 0.078 | CD45 antagonist | 0.078 0.013 CID_125 | CID_125 | |
| 0.076 | 0.028 | 0.076 | Carbonic anhydrase stimulant | |||
| 0.063 | 0.015 | 0.213 | Mannosidase inhibitor | 0.045 0.032 CID_15361578 0.12 0.005 CID_125 0.213 0.003 CID_66849195 | CID_66849195 | |
| 0.083 | 0.037 | 0.083 | Prostaglandin-E synthase inhibitor | 0.073 0.046 CID_125 | ||
| 0.08 | 0.034 | 0.08 | Potassium channel (Tandem pore domain) blocker | |||
| 0.05 | 0.004 | 0.05 | Thyroid hormone agonist | 0.05 0.004 CID_125 | ||
| 0.057 | 0.012 | 0.057 | Nerve growth factor antagonist | |||
| 0.056 | 0.011 | 0.066 | Fumarate hydratase inhibitor | 0.041 0.018 CID_15361578 0.066 0.009 CID_125 0.042 0.017 CID_66849195 | CID_125 | |
| 0.055 | 0.01 | 0.055 | Potassium channel Kv1.1 blocker | 0.048 0.015 CID_15361578 | ||
| 0.061 | 0.016 | 0.062 | Thymidylate synthase inhibitor | 0.062 0.016 CID_125 | CID_125 | |
| 0.082 | 0.038 | 0.091 | Phosphodiesterase VI inhibitor | 0.077 0.046 CID_125 0.091 0.027 CID_66849195 | CID_66849195 | |
| 0.054 | 0.01 | 0.054 | Retinoid X receptor antagonist | 0.037 0.029 CID_15361578 0.042 0.021 CID_125 | ||
| 0.105 | 0.061 | 0.109 | Nav1.1 sodium channel blocker | 0.109 0.057 CID_125 | CID_125 | |
| 0.088 | 0.044 | 0.088 | Caspase 7 inhibitor | 0.084 0.052 CID_125 | ||
| 0.063 | 0.019 | 0.063 | Vanilloid 2 antagonist | 0.05 0.041 CID_125 | ||
| 0.051 | 0.008 | 0.091 | Liver X receptor beta antagonist | 0.091 0.004 CID_125 | CID_125 | |
| 0.053 | 0.01 | 0.053 | Heme oxygenase inhibitor | 0.043 0.03 CID_15361578 0.051 0.012 CID_125 | ||
| 0.133 | 0.09 | 0.139 | Thiol protease inhibitor | 0.139 0.081 CID_125 | CID_125 | |
| 0.062 | 0.019 | 0.079 | Adenosine deaminase inhibitor | 0.079 0.009 CID_125 0.059 0.022 CID_66849195 | CID_125 | |
| 0.046 | 0.003 | 0.075 | Vanilloid 2 agonist | 0.036 0.005 CID_15361578 0.04 0.004 CID_125 0.075 0.002 CID_66849195 | CID_66849195 | |
| 0.165 | 0.123 | 0.386 | Hypolipemic | 0.203 0.092 CID_15361578 0.25 0.067 CID_125 0.386 0.028 CID_66849195 | CID_66849195 | |
| 0.045 | 0.003 | 0.045 | Estrogen-related receptor gamma agonist | 0.028 0.005 CID_125 | ||
| 0.08 | 0.038 | 0.181 | Leukotriene synthesis inhibitor | 0.181 0.006 CID_125 | CID_125 | |
| 0.086 | 0.044 | 0.086 | Nicotinic alpha4beta2 receptor antagonist | 0.082 0.048 CID_15361578 | ||
| 0.059 | 0.018 | 0.061 | Cholesterol esterase inhibitor | 0.061 0.016 CID_15361578 0.061 0.016 CID_125 | CID_125 | |
| 0.086 | 0.045 | 0.14 | Somatostatin 1 agonist | 0.14 0.016 CID_125 | CID_125 | |
| 0.057 | 0.016 | 0.057 | AICAR transformylase inhibitor | 0.053 0.02 CID_125 | ||
| 0.07 | 0.029 | 0.07 | Corticotropin releasing factor 2 receptor antagonist | 0.067 0.034 CID_15361578 | ||
| 0.06 | 0.019 | 0.06 | Potassium channel (Inward rectifier) activator | 0.056 0.025 CID_15361578 | ||
| 0.049 | 0.009 | 0.049 | Lysophosphatidic acid 2 receptor antagonist | 0.028 0.025 CID_125 | ||
| 0.108 | 0.068 | 0.108 | GABA receptor agonist | 0.094 0.085 CID_15361578 0.099 0.078 CID_125 | ||
| 0.07 | 0.03 | 0.074 | Phosphodiesterase 1C inhibitor | 0.062 0.044 CID_15361578 0.074 0.024 CID_125 | CID_125 | |
| 0.153 | 0.113 | 0.215 | P-glycoprotein inhibitor | 0.215 0.055 CID_15361578 0.143 0.128 CID_125 0.175 0.084 CID_66849195 | CID_15361578 | |
| 0.097 | 0.058 | 0.097 | Breast cancer-resistant protein inhibitor | |||
| 0.045 | 0.006 | 0.164 | Sodium/glucose cotransporter inhibitor | 0.024 0.023 CID_15361578 0.081 0.003 CID_125 0.164 0.002 CID_66849195 | CID_66849195 | |
| 0.137 | 0.099 | 0.137 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.107 | 0.069 | 0.107 | Alpha 2b adrenoreceptor antagonist | |||
| 0.052 | 0.014 | 0.078 | Sphingosine kinase 1 inhibitor | 0.078 0.005 CID_125 | CID_125 | |
| 0.057 | 0.019 | 0.057 | Potassium channel (ATP-sensitive) activator | 0.053 0.024 CID_15361578 | ||
| 0.051 | 0.014 | 0.076 | Phosphoglycerate kinase inhibitor | 0.076 0.009 CID_125 | CID_125 | |
| 0.076 | 0.039 | 0.076 | Dopamine agonist | |||
| 0.062 | 0.026 | 0.071 | Sphingosine 1-phosphate receptor 1 antagonist | 0.071 0.018 CID_125 | CID_125 | |
| 0.049 | 0.012 | 0.055 | Delayed rectifier potassium channel blocker | 0.055 0.009 CID_15361578 0.04 0.022 CID_125 | CID_15361578 | |
| 0.067 | 0.03 | 0.067 | Potassium channel intermediate-conductance Ca-activated blocker | 0.057 0.049 CID_15361578 | ||
| 0.157 | 0.12 | 0.157 | Focal adhesion kinase 2 inhibitor | |||
| 0.06 | 0.023 | 0.241 | Heparanase inhibitor | 0.069 0.013 CID_125 0.241 0.002 CID_66849195 | CID_66849195 | |
| 0.052 | 0.016 | 0.052 | Kinesin antagonist | |||
| 0.052 | 0.016 | 0.052 | Kinesin-like protein 1 inhibitor | |||
| 0.119 | 0.083 | 0.119 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.107 | 0.071 | 0.107 | Protein kinase (CK2) alpha inhibitor | |||
| 0.053 | 0.017 | 0.053 | GABA B receptor antagonist | 0.047 0.024 CID_125 | ||
| 0.163 | 0.127 | 0.163 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.061 | 0.026 | 0.064 | Lysine-specific demethylase 1A inhibitor | 0.064 0.023 CID_125 | CID_125 | |
| 0.039 | 0.005 | 0.041 | Nicotinic acid receptor 2 antagonist | 0.041 0.005 CID_15361578 0.033 0.009 CID_125 | CID_15361578 | |
| 0.061 | 0.027 | 0.07 | Epithelial sodium channel blocker | 0.07 0.018 CID_125 | CID_125 | |
| 0.051 | 0.017 | 0.079 | Beta adrenoreceptor agonist | 0.079 0.004 CID_125 | CID_125 | |
| 0.039 | 0.005 | 0.039 | Glutamate (mGluR1) agonist | 0.023 0.021 CID_15361578 0.033 0.008 CID_125 | ||
| 0.052 | 0.019 | 0.052 | Glutamate (mGluR4) antagonist | 0.049 0.022 CID_15361578 0.046 0.025 CID_125 | ||
| 0.075 | 0.041 | 0.075 | Alpha adrenoreceptor agonist | |||
| 0.114 | 0.081 | 0.114 | Nav1.3 sodium channel blocker | 0.106 0.09 CID_125 | ||
| 0.063 | 0.029 | 0.075 | Ornithine carbamoyltransferase inhibitor | 0.048 0.042 CID_15361578 0.075 0.024 CID_125 | CID_125 | |
| 0.072 | 0.039 | 0.074 | Carbonic anhydrase inhibitor | 0.074 0.038 CID_125 0.068 0.041 CID_66849195 | CID_125 | |
| 0.06 | 0.027 | 0.06 | DNA helicase inhibitor | |||
| 0.044 | 0.011 | 0.044 | Retinoid X alpha receptor antagonist | 0.033 0.026 CID_15361578 0.033 0.025 CID_125 | ||
| 0.109 | 0.076 | 0.109 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.036 | 0.004 | 0.036 | Nicotinic acid receptor 1 antagonist | 0.023 0.006 CID_15361578 0.027 0.005 CID_125 | ||
| 0.037 | 0.005 | 0.037 | Alpha 2a adrenoreceptor agonist | |||
| 0.046 | 0.014 | 0.046 | Estrogen-related receptor alpha antagonist | |||
| 0.05 | 0.019 | 0.106 | 5-Alpha-reductase inhibitor | 0.106 0.009 CID_15361578 0.036 0.027 CID_125 | CID_15361578 | |
| 0.076 | 0.045 | 0.076 | HIV-1 reverse transcriptase inhibitor | |||
| 0.049 | 0.019 | 0.049 | Progesterone antagonist | 0.049 0.018 CID_15361578 | ||
| 0.077 | 0.047 | 0.077 | Adenosine A3 receptor antagonist | 0.07 0.058 CID_15361578 0.077 0.047 CID_125 | ||
| 0.049 | 0.019 | 0.054 | Thymidine kinase inhibitor | 0.038 0.033 CID_15361578 0.054 0.016 CID_125 | CID_125 | |
| 0.036 | 0.006 | 0.039 | Dopamine D1 agonist | 0.039 0.005 CID_66849195 | CID_66849195 | |
| 0.047 | 0.018 | 0.047 | TRPM8 blocker | 0.037 0.028 CID_125 | ||
| 0.061 | 0.032 | 0.118 | Carbonic anhydrase XII inhibitor | 0.056 0.034 CID_125 0.118 0.017 CID_66849195 | CID_66849195 | |
| 0.045 | 0.016 | 0.049 | Leukotriene C4 antagonist | 0.049 0.011 CID_125 | CID_125 | |
| 0.052 | 0.024 | 0.069 | Cytokine production stimulant | 0.069 0.007 CID_125 0.068 0.008 CID_66849195 | CID_125 | |
| 0.059 | 0.031 | 0.059 | Opioid agonist | |||
| 0.064 | 0.035 | 0.082 | Carbonic anhydrase IX inhibitor | 0.063 0.036 CID_125 0.082 0.026 CID_66849195 | CID_66849195 | |
| 0.037 | 0.009 | 0.037 | CXC chemokine 2 receptor antagonist | 0.027 0.017 CID_125 | ||
| 0.035 | 0.007 | 0.035 | Hedgehog signaling activator | 0.032 0.01 CID_15361578 0.031 0.011 CID_125 | ||
| 0.04 | 0.012 | 0.04 | Adenosine uptake inhibitor | 0.036 0.022 CID_66849195 | ||
| 0.058 | 0.031 | 0.087 | Leukotriene B4 antagonist | 0.079 0.016 CID_125 0.087 0.013 CID_66849195 | CID_66849195 | |
| 0.108 | 0.081 | 0.116 | Acetylcholine muscarinic antagonist | 0.116 0.071 CID_125 | CID_125 | |
| 0.041 | 0.015 | 0.066 | Ceramide glucosyltransferase inhibitor | 0.066 0.004 CID_125 0.041 0.015 CID_66849195 | CID_125 | |
| 0.084 | 0.058 | 0.09 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.09 0.048 CID_125 | CID_125 | |
| 0.095 | 0.069 | 0.095 | Protein kinase (CK2) inhibitor | |||
| 0.068 | 0.042 | 0.099 | Leukotriene antagonist | 0.099 0.022 CID_125 0.063 0.047 CID_66849195 | CID_125 | |
| 0.042 | 0.016 | 0.042 | Sirtuin 2 inhibitor | |||
| 0.039 | 0.014 | 0.039 | Cholesterol ester transfer protein antagonist | 0.031 0.023 CID_125 | ||
| 0.074 | 0.05 | 0.093 | Lipase inhibitor | 0.093 0.031 CID_125 | CID_125 | |
| 0.029 | 0.004 | 0.046 | Antibiotic Anthracycline-like | 0.021 0.009 CID_15361578 0.029 0.004 CID_125 0.046 0.002 CID_66849195 | CID_66849195 | |
| 0.086 | 0.061 | 0.131 | Interleukin 5 antagonist | 0.131 0.018 CID_15361578 0.124 0.021 CID_125 0.089 0.056 CID_66849195 | CID_15361578 | |
| 0.044 | 0.019 | 0.044 | 5 Hydroxytryptamine 2B agonist | 0.044 0.019 CID_15361578 | ||
| 0.031 | 0.007 | 0.031 | Complement factor 1s inhibitor | 0.025 0.018 CID_15361578 0.027 0.013 CID_125 | ||
| 0.053 | 0.03 | 0.053 | Potassium channel (Inward rectifier) blocker | |||
| 0.071 | 0.048 | 0.071 | Secretase beta inhibitor | |||
| 0.044 | 0.021 | 0.044 | AMPA 4 receptor antagonist | |||
| 0.058 | 0.035 | 0.082 | Ribonucleoside-diphosphate reductase inhibitor | 0.082 0.024 CID_125 | CID_125 | |
| 0.06 | 0.037 | 0.084 | Ribonucleotide reductase inhibitor | 0.084 0.025 CID_125 | CID_125 | |
| 0.073 | 0.05 | 0.073 | Metalloproteinase-9 inhibitor | 0.072 0.053 CID_125 | ||
| 0.039 | 0.016 | 0.073 | Liver X receptor beta agonist | 0.073 0.006 CID_125 | CID_125 | |
| 0.08 | 0.057 | 0.279 | Antineoplastic antibiotic | 0.167 0.027 CID_15361578 0.093 0.049 CID_125 0.279 0.011 CID_66849195 | CID_66849195 | |
| 0.042 | 0.02 | 0.076 | Arginase inhibitor | 0.043 0.02 CID_15361578 0.048 0.016 CID_125 0.076 0.006 CID_66849195 | CID_66849195 | |
| 0.056 | 0.034 | 0.058 | Thromboxane synthase inhibitor | 0.058 0.03 CID_125 | CID_125 | |
| 0.051 | 0.029 | 0.115 | Aldosterone antagonist | 0.115 0.007 CID_15361578 | CID_15361578 | |
| 0.034 | 0.012 | 0.034 | Purinergic P2Y15 antagonist | 0.033 0.012 CID_15361578 0.027 0.022 CID_125 | ||
| 0.077 | 0.055 | 0.077 | Metalloproteinase-2 inhibitor | 0.072 0.062 CID_125 | ||
| 0.084 | 0.062 | 0.197 | Transcription factor NF kappa B stimulant | 0.079 0.072 CID_15361578 0.168 0.013 CID_125 0.197 0.009 CID_66849195 | CID_66849195 | |
| 0.054 | 0.032 | 0.118 | Glucose-6-phosphate translocase inhibitor | 0.077 0.012 CID_125 0.118 0.004 CID_66849195 | CID_66849195 | |
| 0.051 | 0.03 | 0.168 | Phosphorylase inhibitor | 0.099 0.013 CID_125 0.168 0.006 CID_66849195 | CID_66849195 | |
| 0.027 | 0.005 | 0.027 | Retinoid X beta receptor antagonist | 0.021 0.013 CID_15361578 0.02 0.017 CID_125 | ||
| 0.082 | 0.061 | 0.082 | Bcr-Abl kinase inhibitor | |||
| 0.062 | 0.041 | 0.073 | Transcription factor AP-1 inhibitor | 0.073 0.028 CID_66849195 | CID_66849195 | |
| 0.038 | 0.017 | 0.049 | Tubulin agonist | 0.049 0.009 CID_15361578 | CID_15361578 | |
| 0.028 | 0.008 | 0.028 | Imidazoline I1 receptor antagonist | 0.023 0.011 CID_15361578 | ||
| 0.037 | 0.016 | 0.038 | Protein kinase (CK2) beta inhibitor | 0.038 0.015 CID_125 | CID_125 | |
| 0.04 | 0.019 | 0.04 | Opioid delta receptor agonist | |||
| 0.046 | 0.026 | 0.046 | Dihydrofolate reductase inhibitor | 0.044 0.029 CID_125 | ||
| 0.062 | 0.042 | 0.074 | Histone deacetylase SIRT3 inhibitor | 0.074 0.024 CID_125 | CID_125 | |
| 0.041 | 0.021 | 0.041 | Inosine monophosphate dehydrogenase inhibitor | 0.035 0.027 CID_125 | ||
| 0.118 | 0.098 | 0.118 | Activin receptor-like kinase 2 inhibitor | 0.115 0.103 CID_125 | ||
| 0.024 | 0.004 | 0.034 | Telomerase stimulant | 0.021 0.007 CID_15361578 0.026 0.004 CID_125 0.034 0.002 CID_66849195 | CID_66849195 | |
| 0.039 | 0.019 | 0.045 | RNA-directed RNA polymerase inhibitor | 0.045 0.015 CID_125 | CID_125 | |
| 0.057 | 0.038 | 0.057 | Carbonic anhydrase II inhibitor | 0.056 0.038 CID_125 | ||
| 0.028 | 0.009 | 0.028 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.024 | 0.005 | 0.024 | NMDA receptor phencyclidine site antagonist | 0.017 0.009 CID_15361578 0.015 0.011 CID_125 | ||
| 0.038 | 0.019 | 0.038 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.036 | 0.017 | 0.043 | HCV NS5B polymerase inhibitor | 0.043 0.012 CID_125 | CID_125 | |
| 0.05 | 0.032 | 0.05 | Peroxisome proliferator-activated receptor alpha agonist | 0.042 0.039 CID_125 | ||
| 0.028 | 0.01 | 0.031 | Prostaglandin F2 alpha agonist | 0.031 0.009 CID_15361578 0.026 0.011 CID_125 | CID_15361578 | |
| 0.031 | 0.013 | 0.031 | Dopamine autoreceptor agonist | |||
| 0.071 | 0.053 | 0.125 | Histone deacetylase stimulant | 0.091 0.034 CID_125 0.125 0.016 CID_66849195 | CID_66849195 | |
| 0.071 | 0.053 | 0.125 | Histone deacetylase SIRT1 stimulant | 0.091 0.034 CID_125 0.125 0.016 CID_66849195 | CID_66849195 | |
| 0.022 | 0.004 | 0.022 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.012 0.011 CID_15361578 | ||
| 0.034 | 0.016 | 0.035 | Nicotinic alpha3beta4 receptor agonist | 0.035 0.014 CID_15361578 | CID_15361578 | |
| 0.031 | 0.013 | 0.031 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.03 | 0.012 | 0.034 | Thymidine phosphorylase inhibitor | 0.034 0.009 CID_125 | CID_125 | |
| 0.027 | 0.009 | 0.029 | ICAM 1 antagonist | 0.022 0.018 CID_15361578 0.029 0.008 CID_125 | CID_125 | |
| 0.04 | 0.023 | 0.041 | Diamine oxidase inhibitor | 0.041 0.022 CID_125 | CID_125 | |
| 0.126 | 0.109 | 0.126 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.113 | 0.096 | 0.113 | Cytokine production inhibitor | |||
| 0.148 | 0.132 | 0.148 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.04 | 0.025 | 0.04 | MAP3K5 inhibitor | |||
| 0.043 | 0.028 | 0.048 | Sphingosine 1-phosphate receptor 1 agonist | 0.048 0.022 CID_125 | CID_125 | |
| 0.022 | 0.008 | 0.022 | Alpha 2b adrenoreceptor agonist | 0.017 0.016 CID_15361578 0.022 0.008 CID_125 | ||
| 0.028 | 0.014 | 0.031 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.027 0.018 CID_15361578 0.031 0.01 CID_125 | CID_125 | |
| 0.067 | 0.053 | 0.067 | Amidase inhibitor | |||
| 0.036 | 0.021 | 0.036 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.036 0.021 CID_125 | ||
| 0.054 | 0.04 | 0.054 | Carbonic anhydrase I inhibitor | 0.052 0.042 CID_125 0.047 0.046 CID_66849195 | ||
| 0.039 | 0.025 | 0.045 | Farnesoid X receptor agonist | 0.045 0.018 CID_125 | CID_125 | |
| 0.084 | 0.07 | 0.094 | Phosphodiesterase I inhibitor | 0.08 0.077 CID_15361578 0.094 0.053 CID_125 | CID_125 | |
| 0.051 | 0.037 | 0.051 | 5 Hydroxytryptamine 2 agonist | |||
| 0.017 | 0.004 | 0.017 | Progesterone receptor A antagonist | 0.011 0.005 CID_15361578 | ||
| 0.079 | 0.066 | 0.079 | GABA A receptor agonist | 0.075 0.074 CID_15361578 | ||
| 0.029 | 0.016 | 0.029 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.057 | 0.044 | 0.128 | Lipocortins synthesis agonist | 0.128 0.003 CID_15361578 0.076 0.016 CID_66849195 | CID_15361578 | |
| 0.043 | 0.03 | 0.043 | Glutamate (mGluR group III) agonist | |||
| 0.042 | 0.029 | 0.048 | Angiotensin AT1 receptor antagonist | 0.048 0.02 CID_125 | CID_125 | |
| 0.089 | 0.077 | 0.089 | Alpha 2c adrenoreceptor antagonist | |||
| 0.023 | 0.011 | 0.024 | Neuraminidase (Influenza B) inhibitor | 0.02 0.018 CID_15361578 0.024 0.009 CID_125 | CID_125 | |
| 0.023 | 0.011 | 0.023 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.039 | 0.027 | 0.053 | Membrane dipeptidase inhibitor | 0.053 0.013 CID_15361578 | CID_15361578 | |
| 0.057 | 0.045 | 0.069 | Acetylcholine M3 receptor antagonist | 0.069 0.032 CID_125 | CID_125 | |
| 0.022 | 0.01 | 0.022 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.022 0.011 CID_15361578 0.022 0.011 CID_125 | ||
| 0.042 | 0.03 | 0.044 | Carbonic anhydrase IV inhibitor | 0.044 0.029 CID_125 | CID_125 | |
| 0.033 | 0.021 | 0.033 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.043 | 0.032 | 0.052 | Sphingosine 1-phosphate receptor agonist | 0.052 0.023 CID_125 | CID_125 | |
| 0.042 | 0.031 | 0.042 | Leukocyte elastase inhibitor | 0.04 0.033 CID_125 | ||
| 0.049 | 0.037 | 0.072 | Factor III inhibitor | 0.072 0.01 CID_125 0.061 0.017 CID_66849195 | CID_125 | |
| 0.016 | 0.005 | 0.016 | Egl nine homolog 3 inhibitor | |||
| 0.018 | 0.007 | 0.018 | Egl nine homolog 1 inhibitor | |||
| 0.024 | 0.013 | 0.028 | Protease (Human cytomegalovirus) inhibitor | 0.028 0.009 CID_15361578 | CID_15361578 | |
| 0.046 | 0.035 | 0.046 | Glutamate (mGluR group I) agonist | 0.044 0.037 CID_15361578 | ||
| 0.049 | 0.038 | 0.056 | Prolyl endopeptidase inhibitor | 0.048 0.04 CID_15361578 0.056 0.029 CID_125 | CID_125 | |
| 0.02 | 0.009 | 0.056 | Ileal bile acid transport inhibitor | 0.028 0.005 CID_125 0.056 0.003 CID_66849195 | CID_66849195 | |
| 0.061 | 0.051 | 0.132 | Neuraminidase (influenza) inhibitor | 0.066 0.04 CID_125 0.132 0.01 CID_66849195 | CID_66849195 | |
| 0.079 | 0.069 | 0.206 | T cell inhibitor | 0.206 0.007 CID_15361578 0.118 0.015 CID_66849195 | CID_15361578 | |
| 0.044 | 0.034 | 0.044 | Glutamate (mGluR5) agonist | 0.044 0.034 CID_15361578 | ||
| 0.047 | 0.037 | 0.047 | Bombesin 2 receptor antagonist | 0.047 0.039 CID_125 | ||
| 0.077 | 0.067 | 0.103 | Calcium antagonist | 0.103 0.046 CID_15361578 | CID_15361578 | |
| 0.051 | 0.041 | 0.067 | Thromboxane antagonist | 0.067 0.028 CID_125 | CID_125 | |
| 0.026 | 0.016 | 0.026 | Acid ceramidase inhibitor | 0.026 0.018 CID_125 | ||
| 0.015 | 0.006 | 0.017 | Glutamate (mGluR6) agonist | 0.015 0.006 CID_15361578 0.017 0.005 CID_125 | CID_125 | |
| 0.025 | 0.016 | 0.025 | NMDA receptor glycine site antagonist | |||
| 0.033 | 0.024 | 0.033 | Peroxisome proliferator-activated receptor delta agonist | 0.033 0.024 CID_125 | ||
| 0.013 | 0.004 | 0.013 | Thyroid hormone beta agonist | 0.013 0.004 CID_125 | ||
| 0.017 | 0.008 | 0.017 | Thromboxane A2 agonist | 0.016 0.01 CID_15361578 | ||
| 0.085 | 0.076 | 0.085 | DNA directed RNA polymerase inhibitor | |||
| 0.037 | 0.028 | 0.037 | Glucose-6-phosphate dehydrogenase inhibitor | |||
| 0.023 | 0.014 | 0.026 | Isoleucine-tRNA ligase inhibitor | 0.022 0.016 CID_15361578 0.026 0.009 CID_125 0.022 0.018 CID_66849195 | CID_125 | |
| 0.019 | 0.01 | 0.02 | G-protein-coupled receptor 120 agonist | 0.02 0.009 CID_125 | CID_125 | |
| 0.016 | 0.008 | 0.016 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.015 0.011 CID_125 | ||
| 0.024 | 0.015 | 0.043 | Prostaglandin EP2 agonist | 0.043 0.007 CID_125 | CID_125 | |
| 0.047 | 0.039 | 0.062 | Thromboxane A2 antagonist | 0.062 0.027 CID_125 | CID_125 | |
| 0.033 | 0.025 | 0.033 | Glutamate (mGluR4) agonist | |||
| 0.017 | 0.01 | 0.017 | Vitamin D receptor agonist | 0.017 0.011 CID_125 0.016 0.012 CID_66849195 | ||
| 0.102 | 0.094 | 0.102 | Glutamate receptor antagonist | |||
| 0.019 | 0.012 | 0.019 | Somatostatin 3 agonist | |||
| 0.011 | 0.003 | 0.011 | DNA topoisomerase III inhibitor | |||
| 0.025 | 0.018 | 0.025 | Lysophosphatidic acid receptor 1 agonist | 0.024 0.019 CID_15361578 0.023 0.022 CID_125 | ||
| 0.019 | 0.011 | 0.02 | Methylmalonyl-CoA mutase inhibitor | 0.017 0.015 CID_15361578 0.02 0.009 CID_125 | CID_125 | |
| 0.023 | 0.016 | 0.037 | Beta 1 adrenoreceptor agonist | 0.037 0.005 CID_125 | CID_125 | |
| 0.041 | 0.034 | 0.041 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.02 | 0.013 | 0.042 | 5-Alpha-reductase 2 inhibitor | 0.042 0.008 CID_15361578 | CID_15361578 | |
| 0.041 | 0.034 | 0.048 | DNA gyrase subunit A inhibitor | 0.048 0.02 CID_125 | CID_125 | |
| 0.03 | 0.023 | 0.047 | Prostaglandin agonist | 0.03 0.023 CID_15361578 0.047 0.011 CID_125 | CID_125 | |
| 0.012 | 0.006 | 0.012 | Imidazoline I2 receptor antagonist | |||
| 0.023 | 0.016 | 0.023 | CYP24 inhibitor | |||
| 0.02 | 0.014 | 0.02 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.046 | 0.04 | 0.046 | Cannabinoid CB2 receptor antagonist | |||
| 0.026 | 0.02 | 0.03 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.03 0.017 CID_15361578 | CID_15361578 | |
| 0.026 | 0.02 | 0.03 | Lysine carboxypeptidase inhibitor | 0.03 0.016 CID_125 | CID_125 | |
| 0.041 | 0.035 | 0.041 | Purinergic P2Y antagonist | |||
| 0.029 | 0.024 | 0.077 | Liver X receptor antagonist | 0.077 0.006 CID_125 | CID_125 | |
| 0.045 | 0.04 | 0.045 | Benzodiazepine antagonist | |||
| 0.047 | 0.042 | 0.127 | Factor IXa inhibitor | 0.127 0.005 CID_66849195 | CID_66849195 | |
| 0.017 | 0.012 | 0.053 | 5-Alpha-reductase 1 inhibitor | 0.053 0.007 CID_15361578 | CID_15361578 | |
| 0.012 | 0.007 | 0.013 | Thromboxane agonist | 0.013 0.005 CID_125 | CID_125 | |
| 0.052 | 0.047 | 0.052 | Glutamate (mGluR1) antagonist | |||
| 0.029 | 0.024 | 0.029 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.028 | 0.023 | 0.069 | Liver X receptor alpha antagonist | 0.069 0.004 CID_125 | CID_125 | |
| 0.024 | 0.019 | 0.024 | Prostaglandin H2 antagonist | |||
| 0.037 | 0.032 | 0.037 | Kainate receptor antagonist | |||
| 0.037 | 0.032 | 0.037 | Retinoic acid alpha receptor agonist | |||
| 0.032 | 0.028 | 0.038 | Angiotensin II receptor antagonist | 0.038 0.017 CID_125 | CID_125 | |
| 0.015 | 0.011 | 0.018 | Purinergic P2Y1 agonist | 0.018 0.008 CID_125 | CID_125 | |
| 0.026 | 0.023 | 0.035 | Nicotinic alpha4beta2 receptor agonist | 0.035 0.012 CID_15361578 | CID_15361578 | |
| 0.054 | 0.051 | 0.059 | Phosphodiesterase 1B inhibitor | 0.059 0.043 CID_125 | CID_125 | |
| 0.037 | 0.034 | 0.037 | CDK5/p25 inhibitor | |||
| 0.006 | 0.004 | 0.008 | Transcortin receptor antagonist | 0.008 0.003 CID_15361578 | CID_15361578 | |
| 0.007 | 0.004 | 0.007 | Integrin alpha5beta6 antagonist | |||
| 0.013 | 0.01 | 0.013 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.056 | 0.054 | 0.056 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.054 | 0.052 | 0.054 | Acetylcholine M5 receptor antagonist | |||
| 0.015 | 0.013 | 0.015 | Thyroid hormone alpha agonist | |||
| 0.083 | 0.082 | 0.083 | Potassium channel (Voltage-sensitive) activator | |||
| 0.026 | 0.024 | 0.038 | Glucagon receptor antagonist | 0.038 0.015 CID_125 | CID_125 | |
| 0.017 | 0.016 | 0.017 | Alpha 2c adrenoreceptor agonist | |||
| 0.036 | 0.035 | 0.036 | Glutamate (mGluR1a) antagonist | |||
| 0.067 | 0.066 | 0.067 | Orexin receptor 1 antagonist | |||
| 0.029 | 0.028 | 0.029 | Calcitonin receptor agonist | |||
| 0.014 | 0.013 | 0.014 | Thyroid hormone alpha antagonist | |||
| 0.023 | 0.022 | 0.035 | Prostaglandin EP4 antagonist | 0.035 0.013 CID_125 | CID_125 | |
| 0.02 | 0.02 | 0.034 | Prostaglandin E2 agonist | 0.034 0.009 CID_125 | CID_125 | |
| 0.023 | 0.024 | 0.032 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.032 0.016 CID_125 | CID_125 | |
| 0.056 | 0.056 | 0.063 | Neutrophil collagenase inhibitor | 0.063 0.047 CID_125 | CID_125 | |
| 0.033 | 0.034 | 0.042 | Glutamate (mGluR group II) antagonist | 0.042 0.022 CID_125 | CID_125 | |
| 0.014 | 0.016 | 0.015 | Antibiotic Tetracycline-like | 0.015 0.011 CID_15361578 | CID_15361578 | |
| 0.081 | 0.084 | 0.287 | Bronchodilator | 0.287 0.01 CID_125 | CID_125 | |
| 0.037 | 0.04 | 0.058 | Histamine H2 receptor agonist | 0.058 0.016 CID_15361578 | CID_15361578 | |
| 0.026 | 0.029 | 0.032 | 1,3-Beta-glucan synthase inhibitor | 0.03 0.016 CID_125 0.032 0.01 CID_66849195 | CID_66849195 | |
| 0.008 | 0.012 | 0.013 | Purinergic P2Y2 agonist | 0.01 0.008 CID_125 0.013 0.004 CID_66849195 | CID_66849195 | |
| 0.106 | 0.11 | 0.159 | Histone deacetylase SIRT1 inhibitor | 0.159 0.054 CID_125 | CID_125 | |
| 0.068 | 0.072 | 0.073 | Acetylcholine nicotinic antagonist | 0.073 0.064 CID_125 | CID_125 | |
| 0.01 | 0.015 | 0.015 | Prostaglandin EP4 agonist | 0.015 0.01 CID_125 | CID_125 | |
| 0.029 | 0.035 | 0.039 | Melatonin receptor 1A agonist | 0.034 0.021 CID_15361578 0.039 0.015 CID_125 | CID_125 | |
| 0.013 | 0.019 | 0.019 | Adenosine A2 receptor agonist | 0.019 0.009 CID_125 | CID_125 | |
| 0.031 | 0.038 | 0.038 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.038 0.023 CID_15361578 | CID_15361578 | |
| 0.09 | 0.097 | 0.126 | Multidrug resistance-associated protein 1 inhibitor | 0.126 0.042 CID_66849195 | CID_66849195 | |
| 0.011 | 0.018 | 0.019 | Adenosine A2a receptor agonist | 0.019 0.008 CID_125 | CID_125 | |
| 0.095 | 0.102 | 0.11 | Cholinergic antagonist | 0.11 0.084 CID_125 | CID_125 | |
| 0.016 | 0.023 | 0.019 | Progesterone receptor B antagonist | 0.019 0.015 CID_15361578 | CID_15361578 | |
| 0.009 | 0.016 | 0.012 | Purine nucleoside phosphorylase inhibitor | 0.012 0.008 CID_125 | CID_125 | |
| 0.046 | 0.054 | 0.052 | Nicotinic receptor alpha7 subunit antagonist | 0.052 0.039 CID_15361578 0.052 0.04 CID_125 | CID_125 | |
| 0.051 | 0.059 | 0.473 | Selectin antagonist | 0.13 0.021 CID_125 0.473 0.003 CID_66849195 | CID_66849195 | |
| 0.009 | 0.018 | 0.016 | Human herpes virus 5 capsid protein P40 inhibitor | 0.016 0.005 CID_15361578 | CID_15361578 | |
| 0.054 | 0.063 | 0.063 | Neuronal nicotinic receptor antagonist | 0.063 0.051 CID_125 | CID_125 | |
| 0.022 | 0.031 | 0.069 | Glucocorticoid antagonist | 0.069 0.009 CID_15361578 | CID_15361578 | |
| 0.044 | 0.054 | 0.074 | Protein kinase C eta inhibitor | 0.074 0.026 CID_125 | CID_125 | |
| 0.093 | 0.102 | 0.107 | Acetylcholine antagonist | 0.107 0.083 CID_125 | CID_125 | |
| 0.035 | 0.045 | 0.04 | Plasmepsin II inhibitor | 0.04 0.031 CID_125 | CID_125 | |
| 0.024 | 0.034 | 0.028 | Glutamate (mGluR2) antagonist | 0.028 0.023 CID_125 | CID_125 | |
| 0.144 | 0.155 | 0.253 | Growth factor agonist | 0.253 0.03 CID_125 | CID_125 | |
| 0.024 | 0.037 | 0.029 | Epoxide hydrolase 1 inhibitor | 0.029 0.025 CID_15361578 | CID_15361578 | |
| 0.029 | 0.042 | 0.033 | Protein kinase C beta I inhibitor | 0.033 0.026 CID_125 | CID_125 | |
| 0.006 | 0.019 | 0.014 | Beta 3 adrenoreceptor agonist | 0.014 0.006 CID_125 | CID_125 | |
| 0.034 | 0.048 | 0.039 | Oleamide hydrolase inhibitor | 0.039 0.038 CID_125 | CID_125 | |
| 0.056 | 0.07 | 0.072 | Elastase 1 inhibitor | 0.072 0.044 CID_125 | CID_125 | |
| 0.023 | 0.039 | 0.027 | Glucosylceramidase stimulant | 0.027 0.02 CID_15361578 | CID_15361578 | |
| 0.006 | 0.022 | 0.065 | Glucocorticoid agonist | 0.065 0.004 CID_15361578 | CID_15361578 | |
| 0.042 | 0.058 | 0.05 | Adenosine A1 receptor antagonist | 0.05 0.049 CID_125 | CID_125 | |
| 0.034 | 0.051 | 0.063 | Antimetabolite | 0.063 0.024 CID_125 | CID_125 | |
| 0.051 | 0.07 | 0.059 | I kappa B kinase 2 inhibitor | 0.059 0.05 CID_125 | CID_125 | |
| 0.021 | 0.041 | 0.028 | Peptide deformylase inhibitor | 0.028 0.024 CID_15361578 | CID_15361578 | |
| 0.057 | 0.078 | 0.075 | Calcium channel L-type blocker | 0.075 0.045 CID_15361578 | CID_15361578 | |
| 0.031 | 0.053 | 0.041 | Aggrecanase 1 inhibitor | 0.041 0.024 CID_125 | CID_125 | |
| 0.041 | 0.063 | 0.095 | Prostaglandin EP2 antagonist | 0.095 0.02 CID_125 0.071 0.033 CID_66849195 | CID_125 | |
| 0.013 | 0.036 | 0.053 | Corticosteroid-like | 0.053 0.003 CID_15361578 0.023 0.013 CID_66849195 | CID_15361578 | |
| 0.014 | 0.038 | 0.026 | Leukotriene B4 receptor 2 antagonist | 0.026 0.011 CID_125 0.021 0.017 CID_66849195 | CID_125 | |
| 0.035 | 0.06 | 0.053 | CC chemokine 4 receptor antagonist | 0.053 0.023 CID_125 | CID_125 | |
| 0.039 | 0.064 | 0.048 | HCV NS3/NS4A protease inhibitor | 0.048 0.036 CID_15361578 | CID_15361578 | |
| 0.035 | 0.062 | 0.056 | Plasminogen activator inhibitor antagonist | 0.056 0.027 CID_125 | CID_125 | |
| 0.019 | 0.046 | 0.026 | LFA antagonist | 0.026 0.022 CID_15361578 | CID_15361578 | |
| 0.063 | 0.09 | 0.079 | Chymotrypsin inhibitor | 0.079 0.056 CID_125 | CID_125 | |
| 0.041 | 0.071 | 0.108 | Neuraminidase inhibitor | 0.108 0.013 CID_66849195 | CID_66849195 | |
| 0.101 | 0.133 | 0.386 | Thrombolytic | 0.167 0.07 CID_125 0.386 0.013 CID_66849195 | CID_66849195 | |
| 0.129 | 0.161 | 0.195 | Cyclin-dependent kinase 3 inhibitor | 0.195 0.036 CID_125 | CID_125 | |
| 0.101 | 0.135 | 0.15 | Neurotrophic factor | 0.119 0.096 CID_15361578 0.15 0.059 CID_125 | CID_125 | |
| 0.216 | 0.252 | 0.844 | Cyclophilin D inhibitor | 0.517 0.045 CID_125 0.844 0.005 CID_66849195 | CID_66849195 | |
| 0.033 | 0.069 | 0.048 | Mineralocorticoid receptor antagonist | 0.048 0.034 CID_15361578 | CID_15361578 | |
| 0.031 | 0.069 | 0.057 | Microtubule stabilization | 0.056 0.019 CID_15361578 0.057 0.019 CID_66849195 | CID_66849195 | |
| 0.007 | 0.046 | 0.019 | Free fatty acid receptor 1 agonist | 0.019 0.011 CID_125 | CID_125 | |
| 0.022 | 0.061 | 0.049 | HMG CoA reductase inhibitor | 0.049 0.008 CID_15361578 | CID_15361578 | |
| 0.029 | 0.069 | 0.059 | Liver X receptor agonist | 0.059 0.017 CID_125 | CID_125 | |
| 0.013 | 0.054 | 0.03 | Leukotriene B4 receptor 1 antagonist | 0.03 0.018 CID_125 | CID_125 | |
| 0.014 | 0.056 | 0.074 | Protein 30S ribosomal subunit inhibitor | 0.074 0.004 CID_66849195 | CID_66849195 | |
| 0.036 | 0.079 | 0.055 | EphB4 antagonist | 0.055 0.044 CID_125 | CID_125 | |
| 0.03 | 0.078 | 0.147 | Protein 50S ribosomal subunit inhibitor | 0.095 0.014 CID_15361578 0.147 0.007 CID_66849195 | CID_66849195 | |
| 0.003 | 0.05 | 0.019 | Antibiotic Macrolide-like | 0.016 0.009 CID_15361578 0.019 0.007 CID_66849195 | CID_66849195 | |
| 0.006 | 0.054 | 0.021 | Prostaglandin EP1 antagonist | 0.021 0.013 CID_125 | CID_125 | |
| 0.065 | 0.115 | 0.108 | Aminoacyl-tRNA synthetase inhibitor | 0.108 0.038 CID_125 | CID_125 | |
| 0.062 | 0.112 | 0.08 | Protein kinase C delta inhibitor | 0.08 0.077 CID_125 | CID_125 | |
| 0.075 | 0.126 | 0.143 | Histone deacetylase class III inhibitor | 0.143 0.05 CID_125 | CID_125 | |
| 0.023 | 0.08 | 0.047 | HIV-1 protease inhibitor | 0.047 0.025 CID_125 | CID_125 | |
| 0.014 | 0.074 | 0.034 | Prostaglandin D2 agonist | 0.032 0.02 CID_15361578 0.034 0.018 CID_125 | CID_125 | |
| 0.068 | 0.129 | 0.168 | DNA intercalator | 0.091 0.084 CID_125 0.168 0.036 CID_66849195 | CID_66849195 | |
| 0.057 | 0.119 | 0.126 | Falcipain 2 inhibitor | 0.126 0.039 CID_66849195 | CID_66849195 | |
| 0.032 | 0.095 | 0.056 | Glucagon-like peptide 1 agonist | 0.056 0.051 CID_125 | CID_125 | |
| 0.022 | 0.085 | 0.051 | Phosphodiesterase 3B inhibitor | 0.051 0.024 CID_125 | CID_125 | |
| 0.059 | 0.122 | 0.128 | Falcipain inhibitor | 0.128 0.041 CID_66849195 | CID_66849195 | |
| 0.021 | 0.085 | 0.033 | Elastase 3B inhibitor | 0.033 0.016 CID_15361578 | CID_15361578 | |
| 0.021 | 0.085 | 0.033 | Elastase 3A inhibitor | 0.033 0.016 CID_15361578 | CID_15361578 | |
| 0.021 | 0.085 | 0.033 | Elastase 2B inhibitor | 0.033 0.016 CID_15361578 | CID_15361578 | |
| 0.023 | 0.093 | 0.094 | Antibiotic Aminoglycoside-like | 0.036 0.025 CID_125 0.094 0.003 CID_66849195 | CID_66849195 | |
| 0.124 | 0.195 | 0.49 | Tumour necrosis factor alpha release inhibitor | 0.17 0.134 CID_125 0.49 0.015 CID_66849195 | CID_66849195 | |
| 0.05 | 0.127 | 0.078 | Prolactin release inhibitor | 0.078 0.013 CID_125 | CID_125 | |
| 0.024 | 0.107 | 0.063 | Neuraminidase (Influenza A) inhibitor | 0.063 0.01 CID_66849195 | CID_66849195 | |
| 0.028 | 0.113 | 0.05 | Histamine agonist | 0.05 0.04 CID_15361578 | CID_15361578 | |
| 0.033 | 0.124 | 0.056 | Sodium/calcium exchanger inhibitor | 0.056 0.023 CID_125 | CID_125 | |
| 0.066 | 0.158 | 0.155 | Toll-Like receptor 3 antagonist | 0.155 0.013 CID_125 | CID_125 | |
| 0.017 | 0.111 | 0.04 | Toll-Like receptor 4 agonist | 0.04 0.005 CID_66849195 | CID_66849195 | |
| 0.007 | 0.104 | 0.054 | Squalene synthetase inhibitor | 0.054 0.013 CID_66849195 | CID_66849195 | |
| 0.006 | 0.104 | 0.015 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.015 0.005 CID_15361578 | CID_15361578 | |
| 0.189 | 0.291 | 0.38 | MAP kinase kinase 6 inhibitor | 0.38 0.071 CID_15361578 | CID_15361578 | |
| 0.087 | 0.193 | 0.209 | MAP3K9 inhibitor | 0.209 0.012 CID_125 | CID_125 | |
| 0.019 | 0.126 | 0.088 | Prostaglandin E2 antagonist | 0.088 0.017 CID_125 | CID_125 | |
| 0.013 | 0.128 | 0.033 | Melatonin 2 agonist | 0.033 0.023 CID_125 | CID_125 | |
| 0.009 | 0.125 | 0.043 | Prostacyclin antagonist | 0.043 0.016 CID_125 | CID_125 | |
| 0.041 | 0.158 | 0.09 | Phosphodiesterase 3A inhibitor | 0.09 0.042 CID_125 | CID_125 | |
| 0.024 | 0.174 | 0.081 | Nitric oxide donor | 0.06 0.048 CID_15361578 0.081 0.022 CID_66849195 | CID_66849195 | |
| 0.075 | 0.226 | 0.116 | Interleukin 2 antagonist | 0.116 0.052 CID_15361578 | CID_15361578 | |
| 0.039 | 0.204 | 0.086 | Protease inhibitor | 0.086 0.079 CID_125 | CID_125 | |
| 0.025 | 0.215 | 0.053 | Autotaxin inhibitor | 0.053 0.035 CID_125 | CID_125 | |
| 0.058 | 0.251 | 0.38 | Cell adhesion inhibitor | 0.38 0.006 CID_66849195 | CID_66849195 | |
| 0.013 | 0.234 | 0.071 | DNA-dependent protein kinase inhibitor | 0.071 0.011 CID_15361578 | CID_15361578 | |
| 0.068 | 0.301 | 0.374 | Platelet antagonist | 0.16 0.134 CID_125 0.374 0.033 CID_66849195 | CID_66849195 | |
| 0.006 | 0.261 | 0.017 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.017 0.011 CID_66849195 | CID_66849195 | |
| 0.006 | 0.266 | 0.03 | Motilin receptor agonist | 0.03 0.01 CID_66849195 | CID_66849195 | |
| 0.035 | 0.298 | 0.207 | Cell adhesion molecule inhibitor | 0.207 0.009 CID_66849195 | CID_66849195 | |
| 0.045 | 0.312 | 0.126 | mTOR complex 1 inhibitor | 0.126 0.023 CID_15361578 | CID_15361578 | |
| 0.085 | 0.369 | 0.303 | Angiogenesis inhibitor | 0.303 0.091 CID_66849195 | CID_66849195 | |
| 0.014 | 0.338 | 0.067 | DNA gyrase inhibitor | 0.067 0.04 CID_66849195 | CID_66849195 | |
| 0.048 | 0.535 | 0.253 | Antiobesity | 0.253 0.153 CID_66849195 | CID_66849195 | |
| 0.05 | 0.58 | 0.501 | Immunomodulator | 0.195 0.17 CID_125 0.501 0.023 CID_66849195 | CID_66849195 | |
| 0.018 | 0.563 | 0.277 | Anticoagulant | 0.277 0.033 CID_66849195 | CID_66849195 | |
| 0.01 | 0.715 | 0.203 | ATM kinase inhibitor | 0.203 0.003 CID_15361578 | CID_15361578 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |